
<html lang="en"     class="pb-page"  data-request-id="c33d5e46-7ddd-440a-be96-a2e7065cb3d3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2012.55.issue-17;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm300862u"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Noncyclam Tetraamines Inhibit CXC Chemokine Receptor Type 4 and Target Glioma-Initiating Cells" /></meta><meta name="dc.Creator" content="Laia  Ros-Blanco" /></meta><meta name="dc.Creator" content="Judit  Anido" /></meta><meta name="dc.Creator" content="Ramon  Bosser" /></meta><meta name="dc.Creator" content="José  Esté" /></meta><meta name="dc.Creator" content="Bonaventura  Clotet" /></meta><meta name="dc.Creator" content="Ana  Kosoy" /></meta><meta name="dc.Creator" content="Luis  Ruíz-Ávila" /></meta><meta name="dc.Creator" content="Jordi  Teixidó" /></meta><meta name="dc.Creator" content="Joan  Seoane" /></meta><meta name="dc.Creator" content="José I.  Borrell" /></meta><meta name="dc.Description" content="The three stereoisomers of the noncyclam compound 1 (1(R,R), 1(S,S), and the meso form 1(S,R)) and their corresponding tetrahydrochlorides 11 were prepared from (S)- and (R)-2-methylpiperidine. We ..." /></meta><meta name="Description" content="The three stereoisomers of the noncyclam compound 1 (1(R,R), 1(S,S), and the meso form 1(S,R)) and their corresponding tetrahydrochlorides 11 were prepared from (S)- and (R)-2-methylpiperidine. We ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 29, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300862u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300862u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300862u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300862u" /></link>
        
    
    

<title>Noncyclam Tetraamines Inhibit CXC Chemokine Receptor Type 4 and Target Glioma-Initiating Cells | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300862u" /></meta><meta property="og:title" content="Noncyclam Tetraamines Inhibit CXC Chemokine Receptor Type 4 and Target Glioma-Initiating Cells" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0009.jpeg" /></meta><meta property="og:description" content="The three stereoisomers of the noncyclam compound 1 (1(R,R), 1(S,S), and the meso form 1(S,R)) and their corresponding tetrahydrochlorides 11 were prepared from (S)- and (R)-2-methylpiperidine. We have evaluated their inhibitory activity on the CXC chemokine receptor type 4 (CXCR4), toxicity properties, and assessment of their effect on glioma initiating cells (GICs) in comparison with the prototype compound AMD3100. The IC50 values determined on human recombinant (CHO) cells showed very similar inhibitory activities albeit a lower KB for AMD3100, with the 1(R,R) isomer being second in potency. All the compounds showed low cardiac toxicity but, contrary to AMD3100, gave maximum nonlethal doses of around 2.0 mg/kg. The CXCR4 inhibitors had an effect on the state of differentiation of GICs, decreasing the percentage of CD44+ cells in glioblastoma multiform neurospheres in vitro. Moreover, these CXCR4 inhibitors blocked the capacity of cells to initiate orthotopic tumors in immunocompromised mice." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="The three stereoisomers of the noncyclam compound 1 (1(R,R), 1(S,S), and the meso form 1(S,R)) and their corresponding tetrahydrochlorides 11 were prepared from (S)- and (R)-2-methylpiperidine. We have evaluated their inhibitory activity on the CXC chemokine receptor type 4 (CXCR4), toxicity properties, and assessment of their effect on glioma initiating cells (GICs) in comparison with the prototype compound AMD3100. The IC50 values determined on human recombinant (CHO) cells showed very similar inhibitory activities albeit a lower KB for AMD3100, with the 1(R,R) isomer being second in potency. All the compounds showed low cardiac toxicity but, contrary to AMD3100, gave maximum nonlethal doses of around 2.0 mg/kg. The CXCR4 inhibitors had an effect on the state of differentiation of GICs, decreasing the percentage of CD44+ cells in glioblastoma multiform neurospheres in vitro. Moreover, these CXCR4 inhibitors blocked the capacity of cells to initiate orthotopic tumors in immunocompromised mice." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0009.jpeg" /></meta><meta name="twitter:title" content="Noncyclam Tetraamines Inhibit CXC Chemokine Receptor Type 4 and Target Glioma-Initiating Cells" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300862u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300862u">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300862u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300862u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300862u&amp;href=/doi/10.1021/jm300862u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7560-7570</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3005543" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300580y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Noncyclam Tetraamines Inhibit CXC Chemokine Receptor Type 4 and Target Glioma-Initiating Cells</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laia++Ros-Blanco">Laia Ros-Blanco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judit++Anido">Judit Anido</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramon++Bosser">Ramon Bosser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9++Est%C3%A9">José Esté</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bonaventura++Clotet">Bonaventura Clotet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Kosoy">Ana Kosoy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luis++Ru%C3%ADz-%C3%81vila">Luis Ruíz-Ávila</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jordi++Teixid%C3%B3">Jordi Teixidó</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joan++Seoane">Joan Seoane</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+I.++Borrell">José I. Borrell</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Grup d’Enginyeria Molecular, Institut Químic de Sarrià, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, E-08035 Barcelona, Spain and Universitat Autònoma de Barcelona, E-08193 Cerdanyola del Vallès, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Janus Development SL, Parc Científic Barcelona, Baldiri Reixac 10-12, E-08028 Barcelona, Spain</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, E-08916 Badalona, Spain</span></div><div class="corresp-info"><strong>*</strong>Dr. José I. Borrell: phone, +34 932 672 059; fax, +34 932 056 266; e-mail, <a href="/cdn-cgi/l/email-protection#e68cc88fc884899494838a8aa68f9795c893948ac8838293"><span class="__cf_email__" data-cfemail="cda7e3a4e3afa2bfbfa8a1a18da4bcbee3b8bfa1e3a8a9b8">[email protected]</span></a>. Dr. Joan Seoane: phone, +34 934 894 167; fax, +34 934 893 884; e-mail <a href="/cdn-cgi/l/email-protection#6c061f09030d02092c1a04050342020918"><span class="__cf_email__" data-cfemail="d5bfa6b0bab4bbb095a3bdbcbafbbbb0a1">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300862u&amp;href=/doi/10.1021%2Fjm300862u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7560–7570</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 21, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 April 2012</li><li><span class="item_label"><b>Published</b> online</span>29 August 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300862u" title="DOI URL">https://doi.org/10.1021/jm300862u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7560%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLaia%2BRos-Blanco%252C%2BJudit%2BAnido%252C%2BRamon%2BBosser%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D17%26contentID%3Djm300862u%26title%3DNoncyclam%2BTetraamines%2BInhibit%2BCXC%2BChemokine%2BReceptor%2BType%2B4%2Band%2BTarget%2BGlioma-Initiating%2BCells%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7570%26publicationDate%3DSeptember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300862u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">796</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300862u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Noncyclam Tetraamines Inhibit CXC Chemokine Receptor Type 4 and Target Glioma-Initiating Cells&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Laia&quot;,&quot;last_name&quot;:&quot;Ros-Blanco&quot;},{&quot;first_name&quot;:&quot;Judit&quot;,&quot;last_name&quot;:&quot;Anido&quot;},{&quot;first_name&quot;:&quot;Ramon&quot;,&quot;last_name&quot;:&quot;Bosser&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Esté&quot;},{&quot;first_name&quot;:&quot;Bonaventura&quot;,&quot;last_name&quot;:&quot;Clotet&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Kosoy&quot;},{&quot;first_name&quot;:&quot;Luis&quot;,&quot;last_name&quot;:&quot;Ruíz-Ávila&quot;},{&quot;first_name&quot;:&quot;Jordi&quot;,&quot;last_name&quot;:&quot;Teixidó&quot;},{&quot;first_name&quot;:&quot;Joan&quot;,&quot;last_name&quot;:&quot;Seoane&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;I. Borrell&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;7560-7570&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300862u&quot;},&quot;abstract&quot;:&quot;The three stereoisomers of the noncyclam compound 1 (1(R,R), 1(S,S), and the meso form 1(S,R)) and their corresponding tetrahydrochlorides 11 were prepared from (S)- and (R)-2-methylpiperidine. We have evaluated their inhibitory activity on the CXC chemokine receptor type 4 (CXCR4), toxicity properties, and assessment of their effect on glioma initiating cells (GICs) in comparison with the prototype compound AMD3100. The IC50 values determined on human recombinant (CHO) cells showed very similar inhibitory activities albeit a lower KB for AMD3100, with the 1(R,R) isomer being second in potency. All the compounds showed low cardiac toxicity but, contrary to AMD3100, gave maximum nonlethal doses of around 2.0 mg/kg. The CXCR4 inhibitors had an effect on the state of differentiation of GICs, decreasing the percentage of CD44+ cells in glioblastoma multiform neurospheres in vitro. Moreover, these CXCR4 inhibitors blocked the capacity of cells to initiate orthotopic tumors in immunocompromised mice.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300862u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300862u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300862u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300862u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300862u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300862u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300862u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300862u&amp;href=/doi/10.1021/jm300862u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300862u" /></input><a href="/doi/pdf/10.1021/jm300862u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300862u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300862u%26sid%3Dliteratum%253Aachs%26pmid%3D22909088%26genre%3Darticle%26aulast%3DRos-Blanco%26date%3D2012%26atitle%3DNoncyclam%2BTetraamines%2BInhibit%2BCXC%2BChemokine%2BReceptor%2BType%2B4%2Band%2BTarget%2BGlioma-Initiating%2BCells%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D17%26spage%3D7560%26epage%3D7570%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/17" title="Go to Volume 55, Issue 17"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jmcmar.2012.55.issue-17/production/jmcmar.2012.55.issue-17.largecover.jpg" alt="Go to Volume 55, Issue 17"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The three stereoisomers of the noncyclam compound <b>1</b> (<b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> form <b>1</b>(<i>S,R</i>)) and their corresponding tetrahydrochlorides <b>11</b> were prepared from (<i>S</i>)- and (<i>R</i>)-2-methylpiperidine. We have evaluated their inhibitory activity on the CXC chemokine receptor type 4 (CXCR4), toxicity properties, and assessment of their effect on glioma initiating cells (GICs) in comparison with the prototype compound AMD3100. The IC<sub>50</sub> values determined on human recombinant (CHO) cells showed very similar inhibitory activities albeit a lower <i>K</i><sub>B</sub> for AMD3100, with the <b>1</b>(<i>R,R</i>) isomer being second in potency. All the compounds showed low cardiac toxicity but, contrary to AMD3100, gave maximum nonlethal doses of around 2.0 mg/kg. The CXCR4 inhibitors had an effect on the state of differentiation of GICs, decreasing the percentage of CD44+ cells in glioblastoma multiform neurospheres in vitro. Moreover, these CXCR4 inhibitors blocked the capacity of cells to initiate orthotopic tumors in immunocompromised mice.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Gliomas have morphologic and gene-expression characteristics similar to glia, the support cells of the brain, and they include astrocytomas, oligodendrogliomas, mixed oligoastrocytomas, and ependimomas according to their histological characteristics. Gliomas can be divided into four clinical grades on the basis of their histology and prognosis. Grade IV gliomas (glioblastoma, GBM) either arise de novo or progress from lower grade to higher grade over time; the tumor of patients originally diagnosed with a lower grade will often progress to a GBM. Histologically, GBMs exhibit microvascular hyperproliferation and/or necrosis, which normally is surrounded by densely packed tumor cell nuclei referred to as being pseudopalisades.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> GBMs have a propensity to infiltrate throughout the brain, and this invasive nature results in the inability of surgery to completely cure patients. GBMs are highly malignant, are usually recalcitrant to radio- and chemotherapy, and have a median survival of 1–2 years.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Novel molecular-targeted therapies against these devastating tumors are required.</div><div class="NLM_p">Recently, a subpopulation of tumor cells with stem-cell-like properties has been identified in gliomas. These cells, called glioma stem cells or glioma-initiating cells (GICs), are characterized by their self-renewal capacity, their multilineage differentiation properties, their high oncogenic potential, and their ability to generate detached spherical cellular structures (neurospheres) when cultured in serum-free medium. Several markers, most of them previously described for neuroprogenitor cells, have been reported to identify GICs. Specifically, we and others have shown that a glioma subpopulation of cells expressing the cell surface protein, CD44, are enriched for cancer stem cells.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> GICs are considered to be responsible for the initiation, propagation, and recurrence of tumors. Moreover, GICs are resistant to standard therapy. This indicates that GICs are critical therapeutic targets and that more effective therapies will result from approaches aimed at targeting the stem-cell-like component of gliomas.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Our work in the field of anti-HIV entry/fusion inhibitors<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> led to the identification of novel potent HIV-1 entry CXCR4 coreceptor inhibitors targeting CXCR4 coreceptor without cytotoxicity at the tested concentrations.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Among them, compound <b>1</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) was selected as a lead compound because it presents nearly the same level of activity as the reference compounds, <b>1</b> (EC<sub>50</sub> = 0.019 μM) and the bicyclam AMD3100 (<b>2</b>, Plerixafor, EC<sub>50</sub> = 0.002 μM), and shows no cell toxicity at the tested concentrations of up to 25 μg mL<sup>–1</sup>. Compound <b>1</b> was obtained and tested as a mixture of three stereoisomers (<b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> form <b>1</b>(<i>S,R</i>) in an approximate 25:25:50 ratio) due to the presence of two chiral centers introduced from the racemic precursor <i>N</i>-(3-aminopropyl)-2-pipecoline (<b>3</b>).</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Noncyclam CXCR4 Inhibitor <b>1</b>, AMD3100 (<b>2</b>), and Stereoisomers of Compound <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">CXCR4 is a transmembrane receptor that regulates the trafficking and homing of various cell types including stem cells and cancer stem cells. CXCL12 is the ligand of CXCR4 and upon binding to CXCR4 engages several signal transduction pathways including the MAPK and the PI3K-Akt pathways. CXCR4 expression in glioma confers poor prognosis after surgery,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and CXCR4 blockade in mice delays tumor recurrence after irradiation by inhibiting the recruitment of CD11b+ monocytes/macrophages that participate in revascularizing the tumor.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> These results suggest a critical role of CXCR4 in glioma. In addition, there is much evidence that demonstrates the involvement of the CXCL12/CXCR4 pathway in different cell functions critical for glioma development. Among others, the CXCL12/CXCR4 pathway<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> promotes tumor vasculogenesis and angiogenesis in tumor stem-like glioma cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Similarly, the pathway increases cell motility and proliferation in the U-118 human glioma cell line.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In addition, the blockage of CXCR4 induced a significant increase in apoptosis. Taken all together, these results point to CXCR4 as a promising therapeutic target in glioma. Because of the described function of CXCR4 in cancer and stem cells, CXCR4 antagonists could be effective against cancer-initiating cells and, hence, tumor initiation and relapse.</div><div class="NLM_p">We systematically isolate cancer-initiating cells from patient-derived glioma samples, glioma initiating cells (GICs) that we culture and study. GICs grow as neurospheres in culture and can be expanded by serial passaging. In addition, patient-derived GICs are inoculated in the brain of NOD-SCID mice. Tumors arising from GICs maintain the same characteristics as the original human tumor.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p last">Here we report the synthesis of the three stereoisomers of compound <b>1</b> (<b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> form <b>1</b>(<i>S,R</i>)), the evaluation of their compared inhibitory activity on the CXCR4 coreceptor, the evaluation of their toxicity properties, and the assessment of their effect on GICs and glioma initiation in comparison with AMD3100.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">To obtain the three stereoisomers of compound <b>1</b> (<b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> form <b>1</b>(<i>S,R</i>)), it was first necessary to prepare the homochiral amines <b>3</b>(<i>S</i>) and <b>3</b>(<i>R</i>), because the diamine <b>3</b> is only commercially available as the racemic mixture. The Gabriel protocol was selected for the synthesis of <b>3</b>(<i>S</i>) and <b>3</b>(<i>R</i>) starting from the corresponding enantiomeric 2-methylpiperidines <b>4</b>(<i>S</i>) and <b>4</b>(<i>R</i>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Although the resolution of 2-methylpiperidine (<b>4</b>) has been described,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> finally we used commercially available (<i>S</i>)-2-methylpiperidine (<b>4</b>(<i>S</i>)) and (<i>R</i>)-2-methylpiperidine (<b>4</b>(<i>R</i>)) with purities of 97%, the latter one as the HCl salt.</div><div class="NLM_p">As for the nucleophilic substitution of the bromine atom present in the commercially available <i>N</i>-(3-bromopropyl)phthalimide (<b>5</b>), we initially considered the same reaction conditions we have used for the synthesis of similar diamines: an excess of the corresponding cyclic amine in acetone at reflux for 12 h.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> However, in the case of <b>4</b>(<i>S</i>) and <b>4</b>(<i>R</i>), we considered a better approach to use stoichiometric amounts of the chiral amines to minimize their amount and avoid intermediate purifications. A bibliographic search revealed a modification of this protocol described by Jo et al. in which the use of solid K<sub>2</sub>CO<sub>3</sub> to capture HBr formed allows one to use a 1.2:1 ratio between the chiral amine <b>4</b> and the bromo-substituted phthalimide <b>5</b> (or even use stoichiometric amounts).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Furthermore, the use of acetonitrile as solvent allows reducing by half the reaction time (although we preferred to maintain the reflux for 8 h to ensure the total conversion of the reagents). In such modification the hydrolysis of the alkylated intermediates <b>6</b>(<i>S</i>) and <b>6</b>(<i>R</i>) was performed under more mild conditions using hydrazine in EtOH instead of 6 M aqueous HCl.</div><div class="NLM_p">Using such methodology, the 2-methylpiperidines <b>4</b>(<i>S</i>) and <b>4</b>(<i>R</i>) were converted to the alkylated intermediates <b>6</b>(<i>S</i>) and <b>6</b>(<i>R</i>) in 92% and 97% yields, respectively, which were hydrolyzed to the desired homochiral <i>N</i>-(3-aminopropyl)-2-pipecolines <b>3</b>(<i>S</i>) and <b>3</b>(<i>R</i>) in 79% and 73% yields, respectively (total yields greater than 60%).</div><div class="NLM_p">The synthesis of the stereoisomers <b>1</b>(<i>S,S</i>) and <b>1</b>(<i>R,R</i>) was carried out following the methodology previously described by our group for <b>1</b>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Thus, the treatment of terephthaldehyde (<b>7</b>) with 2 equiv of the corresponding amine <b>3</b>(<i>S</i>) and <b>3</b>(<i>R</i>) in anhydrous MeOH at reflux for 24 h in the presence of anhydrous Na<sub>2</sub>SO<sub>4</sub> as the dehydrating agent, followed by filtration and cooling of the resultant filtrate to 0 °C, addition of 2 equiv of NaBH<sub>4</sub>, and stirring for 24 h at room temperature, afforded <b>1</b>(<i>S,S</i>) and <b>1</b>(<i>R,R</i>) as yellow oils in 97% and 83% yields, respectively (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Three Stereoisomers of Compound <b>1</b> (<b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> Form <b>1</b>(<i>S,R</i>)) and the Corresponding Tetrahydrochlorides <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the case of the <i>meso</i> form <b>1</b>(<i>S,R</i>), being an asymmetrically substituted compound, it was necessary to use the monoprotected terephthaldehyde <b>8</b> as previously described by our group.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Although the reductive amination could be initiated either by using <b>3</b>(<i>S</i>) or <b>3</b>(<i>R</i>) at first, we preferred to start with <b>3</b>(<i>S</i>) since it was more readily available because it proceeds from the more commercially accessible (<i>S</i>)-2-methylpiperidine (<b>4</b>(<i>S</i>)). Thus, the reductive amination of <b>8</b> with 1 equiv of <b>3</b>(<i>S</i>) in the same reaction conditions described above for the synthesis of the symmetrical compounds afforded <b>9</b>(<i>S</i>) in 84% yield. <b>9</b>(<i>S</i>) was subsequently hydrolyzed to the aldehyde <b>10</b>(<i>S</i>) with 2 M HCl in 80% yield, which was treated with 1 equiv of <b>3</b>(<i>R</i>) in the same reductive amination conditions to afford the <i>meso</i> form <b>1</b>(<i>S,R</i>) in 83% yield (56% yield from <b>8</b>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><div class="NLM_p last">The resulting stereoisomers <b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> form <b>1</b>(<i>S,R</i>) were converted into the corresponding tetrahydrochlorides <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) upon treatment with HCl in MeOH in almost quantitative yields. Finally, we obtained <b>1</b> and its tetrahydrochloride <b>11</b> as the mixture of the three stereoisomers (<b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> form <b>1</b>(<i>S,R</i>)) for comparison purposes by following the procedure previously described by our group.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Antiviral Activity</h3><div class="NLM_p">As a first way to compare the biological activity in front of the CXCR4 receptor of compounds <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) and establish possible differences that can favor one candidate over the others, we decided to evaluate the anti-HIV activity (EC<sub>50</sub>) and cytotoxicity (CC<sub>50</sub>) in CXCR4+ MT-4 cells.</div><div class="NLM_p">The results shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> demonstrate that there are no significant differences between the three isomers, at least in this test. Consequently, we decided to work in parallel with <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) in the following experiments.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Anti-HIV Activity (EC<sub>50</sub>) and Cytotoxicity (CC<sub>50</sub>) Measurements in MT-4 Cells of Tetrachlorohydrates <b>11</b>, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">CC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0.130 ± 0.04 μM</td><td class="colsep0 rowsep0" align="left">>44 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>(<i>R,R</i>)</td><td class="colsep0 rowsep0" align="left">0.125 ± 0.04 μM</td><td class="colsep0 rowsep0" align="left">>44 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>(<i>S,S</i>)</td><td class="colsep0 rowsep0" align="left">0.137 ± 0.06 μM</td><td class="colsep0 rowsep0" align="left">>44 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>(<i>S,R</i>)</td><td class="colsep0 rowsep0" align="left">0.139 ± 0.03 μM</td><td class="colsep0 rowsep0" align="left">26 ± 10 μM</td></tr></tbody></table></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> ADME-TOX Studies</h3><div class="NLM_p">Since AMD3100 reported cardio toxicity, we were interested in comparing our products with AMD3100 in terms of cardio toxicity and affinity for the CXCR4 receptor. Therefore, both an in vitro CXCR4 antagonist effect assay and a conventional K+ Channel patch-clamp assay were performed for <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) and AMD3100. The antagonist effects of AMD3100, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) on the CXCR4 receptor were determined using human recombinant (CHO) cells following the protocol described by Zhou et al.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The results obtained are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. The IC<sub>50</sub> values obtained for AMD3100, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) indicate that these compounds present very similar inhibitory activities although the <i>K</i><sub>B</sub> (Dissociation constant) is lower for AMD3100, meaning this compound binding with the CXCR4 receptor is stronger than the others tested. The <i>R,R</i> isomer of <b>1</b> was second in terms of potency. For the cardiac toxicity determination, a conventional electrophysiological assay using whole cell patch-clamp technique proposed by Mathes<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> to study effects of the compounds on the hERG channel, was used. Briefly, CHO-K1 cells stably expressing hERG channel were used and compounds were valuated at 5 concentrations to determine the amplitude of hERG potassium channel tail currents. The percentage inhibition of the tail current by each compound is summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, showing that all of the compounds had low cardiac toxicity.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antagonist effect and its related inhibition determination curves for <b>11</b>(<i>R,R</i>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect in the in Vitro Human CXCR4 Receptor Functional of Compounds AMD3100, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>B</sub></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (hERG)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMD3100</td><td class="colsep0 rowsep0" align="left">0.26 μM</td><td class="colsep0 rowsep0" align="left">0.077 μM</td><td class="colsep0 rowsep0" align="left">>100 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>(<i>R,R</i>)</td><td class="colsep0 rowsep0" align="left">0.35 μM</td><td class="colsep0 rowsep0" align="left">0.11 μM</td><td class="colsep0 rowsep0" align="left">>100 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>(<i>S,S</i>)</td><td class="colsep0 rowsep0" align="left">1.1 μM</td><td class="colsep0 rowsep0" align="left">0.32 μM</td><td class="colsep0 rowsep0" align="left">N.C.<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>(<i>S,R</i>)</td><td class="colsep0 rowsep0" align="left">0.79 μM</td><td class="colsep0 rowsep0" align="left">0.24 μM</td><td class="colsep0 rowsep0" align="left">>100 μM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">N.C. = IC<sub>50</sub> value not calculable. Concentration–response curve shows less than 25% effect at the highest tested concentration.</p></div></div></div><div class="NLM_p">To complement such data, we decided to study the acute intravenous toxicity in mice by determining the maximum nonlethal dose and the minimum lethal dose. The acute toxicities of the test items AMD3100, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) were evaluated after their intravenous administration to Hsd:ICR (CD-1) mice, followed by an observation period of 14 days. In the study, 4 groups consisting of 4 animals (2 males and 2 females) each were administered in physiological saline solution at the doses between 1.0 and 4.0 mg/kg.</div><div class="NLM_p">Viability/mortality and clinical signs were recorded daily during the acclimatization and during the first 30 min and at approximately 1, 2, 3, and 5 h after administration on test day 1. Viability/mortality was observed twice daily, and clinical signs were observed once daily during days 2–15. Body weights were recorded once during the acclimatization, on days 1 and 14, and before sacrifice (day 15). At the end of the observation period, all surviving animals and those that were found dead were necropsied, and a macroscopic examination was performed on the principal organ systems and tissues to record any macroscopic alterations related to the treatment.</div><div class="NLM_p">No mortality was recorded in animals administered with AMD3100 at any dose level (1, 2, 3, 3.5, and 4 mg/kg). All animals administered with <b>11</b>(<i>S,R</i>) at 3.0 mg/kg, one male administered with <b>11</b>(<i>S,S</i>) at 2.0 mg/kg, and one female administered with <b>11</b>(<i>R,R</i>) at 2.5 mg/kg died immediately or within 1 min of administration.</div><div class="NLM_p last">On the basis of the results obtained, the maximum nonlethal dose and the minimum lethal dose of the test items when administered intravenously to Hsd:ICR (CD-1) mice for both sexes as well as for males and females separately were as follows: AMD3100 (as no mortality was recorded, it was considered that the minimum lethal dose is >4.0 mg/kg); <b>11</b>(<i>S,S</i>) (both sexes: maximum nonlethal dose, 1.5 mg/kg; minimum lethal dose, 2.0 mg/kg); <b>1</b>(<i>R,R</i>) (both sexes: maximum nonlethal dose, 2.0 mg/kg; minimum lethal dose, 2.5 mg/kg); <b>11</b>(<i>S,R</i>) (both sexes: maximum nonlethal dose, 2.5 mg/kg; minimum lethal dose, 3.0 mg/kg). The results obtained once more indicate that there are not significant differences between the tetrahydrochlorides <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) but pointed to a higher toxicity in vivo of these compounds with respect to AMD3100.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Effect of CXCR4 Inhibitors on GICs and Glioma Initiation</h3><div class="NLM_p">As a first step, to address the effect of CXCR4 inhibitors on patient-derived neurospheres, we decided to assess how the compounds affected the signaling pathways that are downstream of the CXCR4 receptor (the Akt and MAPK pathways). First of all, we decided to determine whether the ligand of the CXCR4 receptor, CXCL12, could induce the Akt and MAPK pathways in our cells. Treatment of neurospheres from three different patients (<i>GBM1</i>, <i>GBM2</i>, and <i>GBM3</i>) with CXCL12 slightly increased phospho-Akt (p-Akt) in GBM1 and GBM2 but not in GBM3. There was no major effect of CXCL12 treatment on phospho-MAPK (p-MAPK) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Two bands were detected in the p-MAPK blot corresponding to p44 and p42 MAPK. Both kinases share many functional roles; however, some specific functions have been assigned to each of them.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MAPK and Akt pathway activation by CXCL12. Neurospheres were dissociated and counted, and an equal number of cells were seeded. After 24 h of EGF, FGF, and B27 starvation, cells were treated with 100 mg/mL of CXCL12 during 1 or 2 h. Levels of p-MAPK, p-Akt, and Tubulin were determined by immunoblotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next decided to compare the effect of the CXCR4 inhibitors on the Akt and MAPK pathways using two different concentrations of compound (1 μM and 100 nM). To perform this experiment we decided to focus our studies on GBM2, the patient-derived neurospheres where CXCL12 was having some effect on p-Akt (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). <b>11</b>(<i>S,R</i>) (ASR226) (at 1 μM) was the only compound that had a slight effect on p-Akt and, interestingly, in total Akt. No major effect was observed on p-MAPK in any of the conditions (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. MAPK and Akt pathway inhibition by CXCR4 inhibitors AMD3100, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>). GBM2 neurospheres were dissociated, counted and an equal number of cells were seeded. Cells were treated or left untreated with CXCR4 inhibitors (1 μM) during 8 h. Levels of MAPK, p-Akt, Akt and Tubulin were determined by immunoblotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We repeated the same experiment treating the cells with the inhibitory compounds (at 1 μM) in the presence or absence of CXCL12. In this experiment, the effect of CXCL12 was not evident. However, and again, a minor effect of <b>11</b>(<i>S,R</i>) on p-Akt and total Akt was observed. Moreover, a slight decrease of p-MAPK was observed in cells treated with <b>11</b>(<i>S,S</i>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. MAPK and Akt pathway inhibition by CXCR4 inhibitors in the presence of CXCL12. GBM2 neurospheres were dissociated and counted. After 24 h of EGF, FGF and B27 starvation cells were treated or left untreated with 1 μM CXCR4 inhibitors AMD3100, <b>11</b>, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) during 8 h and/or CXCL12 (100 ng/mL) during 1 h. Levels of p-MAPK, MAPK, p-Akt, Akt, and Tubulin were determined by immunoblotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In summary, our data indicated that 1 μM <b>11</b>(<i>S,R</i>) had a minor effect on the Akt pathway whereas the rest of the compounds including the commercially available AMD3100 did not have a major effect on the Akt and MAPK pathways. At this point, we decided to assess the effect of the compounds on cell viability and proliferation. To this aim, we treated neurospheres from three patients with the compounds in the presence or absence of CXCL12. After 7 days of treatment, cells were counted. The number of cells after treatment is the result of a balance between the rate of proliferation and the rate of cell death. No major effect was observed in the conditions assayed; all drugs gave >80% viability with the exception of AMD3100, which gave ∼65% with GBM1, indicating that the compounds do not have a major effect on cell proliferation nor viability.</div><div class="NLM_p">We next decided to assess the effect of CXCR4 inhibitors on the state of differentiation of GICs. To determine the state of differentiation, we analyzed the levels of CD44, a well-described marker of cancer-initiating cells. We treated GBM neurospheres obtained from two GBM patients with the CXCR4 inhibitors (AMD3100, <b>11</b>, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>)) and analyzed the levels of CD44 by flow cytometry. The percentage of cells that did not express CD44 (<i>CD44 null</i>) increased in GBM neurospheres from two different patients treated with the CXCR4 inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). As a consequence, the ratio CD44 low/CD44 null decreased in the presence of the CXCR4 inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, bar graphs), indicating that the CXCR4 inhibitors decreased the amount of glioma-initiating cells, most likely inducing cell differentiation.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of CXCR4 inhibitors on the CD44+ cell population in patient-derived GBM neurospheres. GBM neurosphere cultures were dissociated and counted, and an equal number of cells were seeded. Cells were treated with 1 μM of the indicated inhibitors (AMD3100, <b>11</b>, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>)) for 7 days. The percentage of cells expressing CD44 was determined by flow cytometry. Bar graphs show the ratio of CD44 low/CD44 null cells quantified by flow cytometry in the different conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm the effect of CXCR4 inhibition on glioma-initiating cells, we decided to perform an in vivo experiment. For this purpose, we used a glioma model that reproduces the tumor from the patient in mice described in our previous publication by Peñuelas et al. (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Scheme of mouse model for human glioblastoma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We treated GBM neurospheres in culture with AMD3100 and <b>11</b>, the tetrahydrochloride of the mixture of the three stereoisomers (<b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> form <b>1</b>(<i>S,R</i>)), for 7 days. Then we inoculated in the brain of NOD-SCID mice using a stereotactic apparatus the same number of live cells, as analyzed by trypan blue staining, which were pretreated with the indicated compounds. Forty days after inoculation, we monitored tumor growth through magnetic resonance imaging (MRI). Images from the entire mouse brain were obtained, and tumor volume was quantified (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Tumors generated from the cells pretreated with the CXCR4 inhibitors generated smaller and fewer tumors than control cells, confirming that the inhibition of CXCR4 prevents tumor initiation through the decrease of the number of glioma-initiating cells.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of CXCR4 inhibitors AMD3100 and <b>11</b> on tumor growth. GBM1 neurospheres were dissociated and counted, and the same number of living cells was inoculated in the brain of NOD-SCID. Forty days after inoculation, the tumor size was determined through MRI and the tumor volume was quantified. The white box indicates an example of tumor detected by MRI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our results show that CXCR4 inhibition did not have a major effect on the PI3K-Akt and the MAPK pathways in contrast to those by Rubin et al.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, both results may not be comparable because Rubin et al. used U87 and Dacoy, two regular cell lines, whereas we used fresh patient-derived cells. The models are different because, first, established cell lines have been cultured in artificial conditions for a long time diverging from the characteristics of a real tumor and, second, our cells are undifferentiated and enriched in GICs.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We obtained the three stereoisomers of compound <b>1</b>, <b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> form <b>1</b>(<i>S,R</i>), starting from the commercially available (<i>S</i>)-2-methylpiperidine (<b>4</b>(<i>S</i>)) and (<i>R</i>)-2-methylpiperidine (<b>4</b>(<i>R</i>)) in good overall yields by following our general methodology for the preparation of such tetraamines.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The anti-HIV activity (EC<sub>50</sub>) and cytotoxicity (CC<sub>50</sub>) in MT-4 cells of the corresponding tetrahydrochlorides, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>), were evaluated in comparison to compounds <b>11</b> (the tetrahydrochloride of the mixture of the three stereoisomers) and AMD3100. There were no significant differences between the three isomers. Furthermore, the IC<sub>50</sub> values of AMD3100, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) were determined on human recombinant (CHO) cells showing that these compounds presented very similar inhibitory activities, although the <i>K</i><sub>B</sub> was lower for AMD3100, with the <b>11</b>(<i>R,R</i>) isomer being second in potency.</div><div class="NLM_p">Toxicity studies for AMD3100, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) were carried out to assess the safety of such compounds for possible use in humans. All compounds tested induced low cardiac toxicity. The evaluation of the acute intravenous toxicity in mice showed that no mortality was recorded in animals administered with AMD3100 at any dose level, but compounds <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) gave a maximum nonlethal dose of ∼2.0 mg/kg.</div><div class="NLM_p last">We found that these CXCR4 inhibitors affect the state of differentiation of GICs, decreasing the percentage of CD44+ cells in GBM neurospheres in vitro. Moreover, and expected based on the effect on the CD44+ cells, CXCR4 inhibitors prevent the capacity of cells to initiate orthotopic tumors in immunocompromised mice. Our results indicate that the CXCR4 inhibitors tested could be effective against GICs, preventing tumor initiation and recurrence and most likely metastasis in other tumor types.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p last">Commercial reagents (Fluka, Aldrich) were used without purification. The (<i>S</i>)-2-methylpiperidine (<b>4</b>(<i>S</i>)) and the (<i>R</i>)-2-methylpiperidine (<b>4</b>(<i>R</i>)), this later as hydrochloride, were purchased from Aldrich (Cat. no. 522902) and Astatech USA (Cat. no. 64253), respectively. IR spectra were recorded in a Nicolet Magna 560 Fourier transform infrared (FTIR) spectrophotometer. Wavenumbers (ν) are expressed in cm<sup>–1</sup>. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded in a Varian Gemini 300HC instrument (operating at a field strength of 300 and 75.5 MHz, respectively) or a Varian Gemini 400-MR instrument (<sup>1</sup>H NMR 400 MHz and <sup>13</sup>C NMR 100.6 MHz). Chemical shifts are reported in parts per million (δ-scale), and coupling constants (<i>J</i>) are reported in Hz by using, in the case of <sup>1</sup>H NMR spectroscopy, tetramethylsilane (TMS) or sodium 2,2,3,3-tetradeutero-3-(trimethylsilyl)propionate (TSPNa) as an internal standard and, in the case of <sup>13</sup>C NMR spectra, solvent residual peak was taken as reference: CDCl<sub>3</sub> at 77.0 ppm, d6-DMSO (dimethyl sulfoxide) at 39.5 ppm, and CD<sub>3</sub>OD in D<sub>2</sub>O at 49.5 ppm. Standard and peak multiplicities are designated as follows: s (singlet), d (doublet), dd (doublet of doublets), t (triplet), q (quartet), qn (quintet), m (multiplet), br (broad signal). MS data (<i>m</i>/<i>z</i> (%), EI, 70 eV) were obtained by using an Agilent Technologies 5975 spectrometer and a Hewlett-Packard HP5988A quadrupole mass spectrometer operating in electronic ionization (EI) mode at 70 eV and at 4 kV accelerating potential, or a Bruker Biotoff II spectrometer operating in electrospray ionization (ESI) mode with a time of flight (TOF) detector. High-resolution mass spectrometry (HRMS) data were obtained by using a VG AutoSpec (Micromass Instruments) Trisector EBE high-resolution spectrometer (EI mode), a Bruker Biotof II mass spectrometer (ESI-TOF mode), or a Bruker Autoflex spectrometer (MALDI-TOF mode, HCCA matrix). Elemental microanalyses were obtained on a Carlo–Erba CHNS-O/EA 1108 analyzer. Specific optical rotations ([α]<sub>D</sub>) were measured with a Perkin-Elmer 241 polarimeter. Sodium D line (589 nm) and a path length of 1 dm were used for measuring at room temperature. The purity of each tested compound (>95%) was determined on an Agilent 1200 LC instrument using a XTerra RP18 column (125 Å, 5 μm, 3 mm × 250 mm, with a flow rate of 0.75 mL/min and detection at 220 nm) using a 95:5 mixture of (NaH<sub>2</sub>PO<sub>4</sub>, pH = 7 + 0.1% acetonitrile)/(acetonitrile/MeOH 75:25) as eluent.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (<i>S</i>)-<i>N</i>-(3-(2-Pipecolin-1-yl)propyl)phthalimide (<b>6</b>(<i>S</i>))</h3><div class="NLM_p last">A solution of 0.41 mL (0.34 g, 3.3 mmol) of (<i>S</i>)-(+)-2-methylpiperidine (<b>4</b>(<i>S</i>)) in 10 mL of acetonitrile was treated with 0.82 g (3.0 mmol) of <i>N</i>-(3-bromopropyl)phthalimide (<b>5</b>) and 0.70 g (5.0 mmol) anhydrous K<sub>2</sub>CO<sub>3</sub> for 8 h at reflux. After concentration, the residue was diluted with 30 mL CH<sub>2</sub>Cl<sub>2</sub> and washed with water. The organic layers were combined, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated to give <b>6</b>(<i>S</i>) as a yellow oil (0.79 g; 92%). IR (film) ν (cm<sup>–1</sup>): 2931, 2854, 2790, 1772, 1712 (C═O), 1396, 1032 (C–N), 720. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.84 (dd, <sup>3</sup><i>J</i> = 5.5 Hz, <sup>4</sup><i>J</i> = 3.0 Hz, 2H, H–C6), 7.71 (dd, <sup>3</sup><i>J</i> = 5.5 Hz, <sup>4</sup><i>J</i> = 3.0 Hz, 2H, H–C7), 3.70 (m, 2H, H–C1), 2.78 (m, 2H, H–C3, H–C1a), 2.38 (m, 1H, H–C3), 2.24 (m, 1H, H–C5a), 2.09 (m, 1H, H–C1a), 1.85 (qn, <sup>3</sup><i>J</i> = 7.5, 2H, H–C2), 1.62–1.42 (m, 4H, H–C2a, H–C3a, H–C4a), 1.24 (m, 2H, H–C3a, H–C4a), 1.03 (d, <i>J</i> = 6.5 Hz, 3H, H–C6a). <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ (ppm): 168.3 (C4), 133.8 (C7), 132.2 (C5), 123.1 (C6), 55.8 (C5a), 51.8 (C3), 51.4 (C1a), 36.7 (C1), 34.5 (C4a), 26.1 (C2), 24.6 (C2a), 23.8 (C3a), 18.7 (C6a). MS (ESI-TOF) <i>m</i>/<i>z</i> (%): 287.2 (100) [<i>M</i><sup><i>+</i></sup>+H], 214.1 (2), 158.0 (5), 141.0 (4), 105.0 (6). HRMS (ESI-TOF) calculated for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub> [M+1]<sup>+</sup>: 287.1754; found: 287.1750. Anal. calculated for C<sub>17</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>: C 71.30, H 7.74, N 9.78; found: C 70.95, H 8.03, N 9.78.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (<i>R</i>)-<i>N</i>-(3-(2-Pipecolin-1-yl)propyl)phthalimide (<b>6</b>(<i>R</i>))</h3><div class="NLM_p last">A solution of (<i>R</i>)-(+)-2-methylpiperidine hydrochloride (<b>4</b>(<i>R</i>)·HCl) in 10% NaOH was extracted with CH<sub>2</sub>Cl<sub>2</sub> to obtain the free amine <b>4</b>(<i>R</i>). A solution of 0.83 g (8.3 mmol) of (<i>R</i>)-(+)-2-methylpiperidine (<b>4</b>(<i>R</i>)) in 20 mL acetonitrile was treated with 1.65 g (6.0 mmol) <i>N</i>-(3-bromopropyl)phthalimide (<b>5</b>) and 1.50 g (11 mmol) of anhydrous K<sub>2</sub>CO<sub>3</sub> for 8 h at reflux. After concentration, the residue was diluted with 30 mL CH<sub>2</sub>Cl<sub>2</sub> and washed with water. The organic layers were combined, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated to give <b>6</b>(<i>R</i>) as a yellow oil (1.67 g; 97%). IR (film) ν (cm<sup>–1</sup>): 2930, 2856, 2791, 1772, 1713 (C═O), 1378, 1031 (C–N), 720. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.84 (m, 2H, H–C6), 7.71 (m, 2H, H–C7), 3.70 (m, 2H, H–C1), 2.77 (m, 2H, H–C1a, H–C3), 2.38 (m, 1H, H–C3), 2.26 (m, 1H, H–C5a), 2.10 (dt, <sup>2</sup><i>J</i> = 10.0 Hz, <sup>3</sup><i>J</i> = 4.0 Hz, 1H, H–C1a), 1.85 (qn, <sup>3</sup><i>J</i> = 7.5, 2H, HC2), 1.64–1.43 (m, 4H, H–C2a, H–C3a, HC4a), 1.24 (m, 2H, H–C3a, H–C4a), 1.03 (d, <i>J</i> = 6.5 Hz, 3H, H–C6a). <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ (ppm): 168.3 (C4), 133.8 (C7), 132.2 (C5), 123.1 (C6), 55.8 (C5a), 51.8 (C3), 51.4 (C1a), 36.7 (C1), 34.5 (C4a), 26.1 (C2), 24.6 (C2a), 23.8 (C3a), 18.7 (C6a).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (<i>S</i>)-<i>N</i>-(3-Aminopropyl)-2-pipecoline (<b>3</b>(<i>S</i>))</h3><div class="NLM_p last">A solution of 0.65 g (2.3 mmol) of (<i>S</i>)-<i>N</i>-(3-(2-pipecolin-1-yl)propyl)phthalimide (<b>6</b>(<i>S</i>)) in 10 mL of ethanol was treated with 0.43 mL (8.8 mmol) of hydrazine hydrate under reflux for 1 h. The white precipitate of phthalhydrazide was filtered, and the filtrate was concentrated. After diluting the residue with 5 mL of AcOEt, a new precipitate of phthalhydrazide appeared, which was filtered off. The filtrate was concentrated to dryness to give 0.28 g (1.81 mmol, 79%) of <b>3</b>(<i>S</i>) as a pale yellow oil. IR (film) ν (cm<sup>–1</sup>): 3293 (N–H), 2930, 2855, 2788, 1575, 1470, 1374, 1329. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 2.87 (m, 1H, H–C3), 2.72 (m, 3H, H–C1, H–C1a), 2.35 (m, 1H, H–C3), 2.26 (m, 1H, H–C5a), 2.12 (m, 1H, H–C1a), 1.80–1.50 (m, 8H, H–C2, H–C2a, H–C3a, H–C4a, NH<sub>2</sub>), 1.28 (m, 2H, H–C3a, H–C4a), 1.06 (d, <sup>3</sup><i>J</i> = 6.0 Hz, 3H, H–C6a). <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ (ppm): 55.9 (C5a), 52.0 (C3), 51.7 (C1a), 41.0 (C1), 34.6 (C4a), 29.4 (C2), 26.1 (C2a), 23.9 (C3a), 19.0 (C6a). MS (EI) <i>m</i>/<i>z</i> (%): 156.2 (7) [M]<sup>+</sup>, 112.2 (100), 98.2 (100). HRMS (EI) calculated for C<sub>9</sub>H<sub>20</sub>N<sub>2</sub> [M]<sup>+</sup>: 156.1626; found: 156.1621.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>R</i>)-<i>N</i>-(3-Aminopropyl)-2-pipecoline (<b>3</b>(<i>R</i>))</h3><div class="NLM_p last">As described above for <b>3</b>(<i>S</i>) but using 0.74 g (2.6 mmol) of (<i>R</i>)-<i>N</i>-(3-(2-pipecolin-1-yl)propyl)phthalimide (<b>6</b>(<i>R</i>)) in 10 mL of ethanol and 0.50 mL (10 mmol) of hydrazine hydrate to give 0.30 g (1.9 mmol, 73%) of <b>3</b>(<i>R</i>) as a yellow oil. IR (film) ν (cm<sup>–1</sup>): 3273 (N–H), 2930, 2855, 2789, 1576, 1472, 1374, 1329. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 2.86 (dt, <sup>2</sup><i>J</i> = 11.5 Hz, <sup>3</sup><i>J</i> = 4.0 Hz, 1H, H–C3), 2.73 (m, 3H, H–C1, H–C1a), 2.35 (m, 1H, H–C3), 2.26 (m, 1H, H–C5a), 2.11 (dt, <sup>2</sup><i>J</i> = 11.0 Hz, <sup>3</sup><i>J</i> = 3.0 Hz, 1H, H–C1a), 1.67–1.51 (m, 8H, H–C2, H–C2a, H–C3a, H–C4a, NH<sub>2</sub>), 1.27 (m, 2H, H–C3a, H–C4a), 1.06 (d, <sup>3</sup><i>J</i> = 6.0 Hz, 3H, H–C6a). <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ (ppm): 55.9 (C5a), 52.1 (C3), 51.8 (C1a), 41.0 (C1), 34.7 (C4a), 29.5 (C2), 26.2 (C2a), 24.0 (C3a), 19.1 (C6a). MS (EI) <i>m</i>/<i>z</i> (%): 156.1 (2) [M]<sup>+</sup>, 112.2 (100), 98.1 (68). HRMS (EI) calculated for C<sub>9</sub>H<sub>20</sub>N<sub>2</sub> [M]<sup>+</sup>: 156.1626; found: 156.1624.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (<i>S</i>)-<i>N</i>,<i>N</i>′-(1,4-Phenylenebis(methylene))bis(3-((<i>S</i>)-2-methylpiperidin-1-yl)propan-1-amine) Tetrahydrochloride (<b>11</b>(<i>S,S</i>))</h3><div class="NLM_p last"> Terephthalaldehyde (<b>7</b>) (0.10 g (0.71 mmol)), 0.23 g (1.45 mmol) of (<i>S</i>)-<i>N</i>-(3-aminopropyl)-2-pipecoline (<b>3</b>(<i>S</i>)) and Na<sub>2</sub>SO<sub>4</sub> were mixed in 6 mL of anhydrous MeOH, and the mixture was heated at reflux under N<sub>2</sub> atmosphere for 24 h. The solid was filtered, and the intermediate imine in MeOH was cooled to 0 °C and treated with 0.06 g (1.45 mmol) of solid NaBH<sub>4</sub>. The reaction mixture was stirred at room temperature overnight. Then water was added, and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were combined, washed with brine, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated to give 0.29 g (0.67 mmol, 97%) of <b>1</b>(<i>S,S</i>) as a yellow oil. IR (film) ν (cm<sup>–1</sup>): 3282 (N–H), 2929, 2854, 2793, 1449, 1372. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.30 (m, 4H, H–C2b), 3.79 (d, 4H, H–Cα), 2.92 (m, 2H, H–C1a), 2.79 (m, 2H, H–C3), 2.68 (m, 4H, H–C1), 2.44–2.33 (m, 8H, H–C3, H–C5a, H–C1a), 2.16 (m, 2H, NH), 1.80–1.48 (m, 12H, H–C2, H–C2a, H–C4a, H–C3a), 1.29 (m, 4H, H–C4a, H–C3a), 1.07 (d, 6H, <sup>3</sup><i>J</i> = 8.0 Hz, H–C6a). <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ (ppm): 138.7 (C1b), 127.8 (C2b), 55.8 (C5a), 53.6 (Cα), 52.2 (C3), 52.1 (C1a), 48.2 (C1), 34.7 (C4a), 26.2 (C2a), 25.7 (C2), 23.9 (C3a), 19.1 (C6a). MS (CI) <i>m</i>/<i>z</i> (%): 415.3 (100), 258.2 (42), 112.0 (51). HRMS (CI) calculated for C<sub>26</sub>H<sub>47</sub>N<sub>4</sub> [M+1]<sup>+</sup>: 415.3801; found: 415.3811. <b>1</b>(<i>S,S</i>) was converted to the corresponding tetrahydrochloride <b>11</b>(<i>S</i>,<i>S</i>) in almost quantitative yield upon treatment with methanolic HCl in excess followed by concentration of the resulting solution. [α]<sub>D</sub> = +15.3 (<i>c</i> = 1.03, MeOH). IR (KBr) ν (cm<sup>–1</sup>): 3412, 2942, 2745, 1449, 553. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ (ppm) 7.58 (s, 4H, H–C2b), 4.32 (s, 4H, H–Cα), 3.73–3.51 (m, 2H, H–C1a), 3.41–2.98 (m, 12H, H–C1, H–C3, H–C5a, H–C1a), 2.26–1.52 (m, 16H, H–C2, H–C2a, H–C3a, H–C4a), 1.34 (d, 6H, <sup>3</sup><i>J</i> = 4.0 Hz, H–C6a). <sup>13</sup>C NMR (100.6 MHz, D<sub>2</sub>O) δ (ppm): 132.6 (C1b), 131.3 (C2b), 60.7 (C5a), 53.0 (Cα), 51.4 (C3), 50.0 (C1a), 44.8 (C1), 32.1 (C4a), 23.6 (C2a), 22.0 (C2), 20.7 (C3a), 17.8 (C6a). Anal. calculated for C<sub>26</sub>H<sub>50</sub>N<sub>4</sub>Cl<sub>4</sub>·0.5H<sub>2</sub>O: C 54.83, H 9.03, N 9.84; found: C 54.50, H 9.37, N 9.51.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (<i>R</i>)-<i>N</i>,<i>N</i>′-(1,4-Phenylenebis(methylene))bis(3-((<i>R</i>)-2-methylpiperidin-1-yl)propan-1-amine) Tetrahydrochloride (<b>11</b>(<i>R,R</i>))</h3><div class="NLM_p last">As above for <b>1</b>(<i>S,S</i>) but using 0.07 g (0.48 mmol) of terephthalaldehyde (<b>7</b>), 0.15 g (0.96 mmol) of (<i>R</i>)-<i>N</i>-(3-aminopropyl)-2-pipecoline (<b>3</b>(<i>R</i>)), and 0.04 g (0.96 mmol) of solid NaBH<sub>4</sub> to give 0.17 g (0.4 mmol, 83%) of <b>1</b>(<i>R,R</i>) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.31 (s, 4H, H–C2b), 3.79 (d, 4H, H–Cα), 2.91 (m, 2H, H–C1a), 2.78 (m, 2H, H–C3), 2.68 (m, 4H, H–C1), 2.43–2.32 (m, 8H, H–C3, H–C5a, H–C1a), 2.16 (m, 2H, NH), 1.79–1.49 (m, 12H, H–C2, H–C2a, H–C3a, H–C4a), 1.28 (m, 4H, H–C4a, H–C3a), 1.07 (d, 6H, <sup>3</sup><i>J</i> = 8.0 Hz, H–C6a). MS (CI) <i>m</i>/<i>z</i> (%): 415.3 (100), 258.1 (31), 112.0 (53). HRMS (CI): calculated for C<sub>26</sub>H<sub>47</sub>N<sub>4</sub> [M+1]<sup>+</sup>: 415.3801; found: 415.3800. <b>1</b>(<i>R,R</i>) was converted to the corresponding tetrahydrochloride <b>11</b>(<i>R,R</i>) in almost quantitative yield upon treatment with methanolic HCl in excess followed by concentration of the resulting solution. [α]<sub>D</sub> = −16.3 (<i>c</i> = 1.01, MeOH). IR (KBr) ν (cm<sup>–1</sup>): 3423, 2943, 2743, 1451, 553. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ (ppm) 7.59 (s, 4H, H–C2b), 4.33 (s, 4H, H–Cα), 3.73–3.52 (m, 2H, H–C1a), 3.42–3.00 (m, 12H, H–C1, H–C3, H–C5a, H–C1a), 2.26–1.52 (m, 16H, H–C2, H–C2a, H–C3a, H–C4a), 1.37 (d, 6H, <sup>3</sup><i>J</i> = 8.0 Hz, H–C6a). <sup>13</sup>C NMR (100.6 MHz, D<sub>2</sub>O) δ (ppm): 132.6 (C1b), 131.3 (C2b), 60.7 (C5a), 53.0 (Cα), 51.4 (C3), 50.0 (C1a), 44.8 (C1), 32.1 (C4a), 23.6 (C2a), 22.0 (C2), 20.7 (C3a), 17.8 (C6a). Anal. calculated for C<sub>26</sub>H<sub>50</sub>N<sub>4</sub>Cl<sub>4</sub>·0.5H<sub>2</sub>O: C 54.83, H 9.03, N 9.84; found: C 54.55, H 9.28, N 9.51.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (<i>S</i>)-<i>N</i>-(4-(Diethoxymethyl)benzyl)-3-(2-methylpiperidin-1-yl)propan-1-amine (<b>9</b>(<i>S</i>))</h3><div class="NLM_p last">4-(Diethoxymethyl)benzaldehyde (<b>8</b>) (0.35 g (1.6 mmol)), 0.25 g (1.6 mmol) of (<i>S</i>)-<i>N</i>-(3-aminopropyl)-2-pipecoline (<b>3</b>(<i>S</i>)), and Na<sub>2</sub>SO<sub>4</sub> were mixed in 5 mL of anhydrous MeOH, and the mixture was held at reflux under N<sub>2</sub> atmosphere for 24 h. The solid was filtered and the intermediate imine in MeOH was cooled to 0 °C and treated with 0.056 g (1.45 mmol) of solid NaBH<sub>4</sub>. The reaction mixture was stirred at room temperature overnight. Then water was added, and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were combined, washed with brine, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated to give 0.47 g (1.3 mmol, 84%) of the <b>9</b>(<i>S</i>) as a brown oil. IR (film) ν (cm<sup>–1</sup>): 3283 (N–H), 2973, 2930, 2798, 1663 (C═C), 1444, 1371, 1114, 1055. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.44 (m, 2H, H–C3b), 7.34 (m, 2H, H–C2b), 5.49 (s, 1H, H–C5b), 3.82 (d, <sup>3</sup><i>J</i> = 9.0 Hz, 2H, H–Cα), 3.72–3.44 (m, 4H, H–C6b), 2.94 (m, 1H, H–C1a), 2.83 (m, 1H, H–C3), 2.71 (m, 2H, H–C1), 2.48–2.36 (m, 3H, H–C3, H–C5a, C1a), 2.21 (m, 1H, NH), 1.84–1.55 (m, 8H, H–C2, H–C2a, H–C3a, H–C4a), 1.24 (m, 6H, H–C7b), 1.09 (d, <sup>3</sup><i>J</i> = 6.5 Hz, 3H, H–C6a). <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ (ppm): 140.1 (C1b), 137.8 (C4b), 127.9 (C2b), 126.7 (C3b), 101.4 (C5b), 64.7 (C5a), 61.0 (C6b), 56.0 (C1a), 53.6 (C3), 52.2 (C1), 48.2 (Cα), 34.4 (C4a), 25.9 (C2), 25.5 (C2a), 23.8 (C3a), 18.9 (C6a), 15.1 (C7b). MS (EI) <i>m</i>/<i>z</i> (%): 348 (3), 303 (6), 165 (14), 155 (11), 126 (15), 112 (100), 98 (34), 91 (12). HRMS (CI) calculated for C<sub>21</sub>H<sub>36</sub>N<sub>2</sub>O<sub>2</sub> [M]<sup>+</sup>: 348.2777; found: 348.2778.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>S</i>)-4-((3-(2-Methylpiperidin-1-yl)propylamino)methyl)benzaldehyde (<b>10</b>(<i>S</i>)) </h3><div class="NLM_p last">The intermediate aminoacetal <b>9</b>(<i>S</i>) (0.50 g (1.42 mmol)) was treated with 5 mL of 2 M HCl at room temperature for 2 h. The resulting mixture was basified with NaOH and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were combined, washed with brine, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated to give 0.32 g (1.14 mmol, 80%) of the desired product <b>10</b>(<i>S</i>) as a brown oil. IR (film) ν (cm<sup>–1</sup>): 3281 (N–H), 2929, 2852, 2797, 2729, 1701 (C═O), 1606 (C═C), 1444, 1371, 1209. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 10.00 (s, 1H, H–C5b), 7.84 (d, <sup>3</sup><i>J</i> = 8.0 Hz, 2H, H–C3b), 7.50 (d, <sup>3</sup><i>J</i> = 8.0 Hz, 2H, H–C2b), 3.87 (s, 2H, H–Cα), 2.90 (m, 1H, H–C1a), 2.79 (m, 1H, H–C3), 2.66 (t, <sup>3</sup><i>J</i> = 7.0 Hz, 2H, H–C1), 2.42–2.36 (m, 2H, H–C3, H–C5a), 2.20–1.96 (m, 2H, H–C1a, NH), 1.75–1.55 (m, 6H, H–C2, H–C2a, H–C4a, H–C3a), 1.34–1.24 (m, 2H, H–C4a, H–C3a), 1.09 (d, <sup>3</sup><i>J</i> = 6.5 Hz, 3H, H–C6a). <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ (ppm): 192.0 (C5b), 147.8 (C1b), 135.3 (C4b), 129.9 (C3b), 128.5 (C2b), 56.1 (C5a), 53.7 (Cα), 52.3 (C3), 52.0 (C1a), 48.5 (C1), 34.5 (C4a), 26.0 (C2a), 25.8 (C2), 23.8 (C3a), 18.9 (C6a). MS (EI) <i>m</i>/<i>z</i> (%): 274 (6), 183 (3), 155 (7), 126 (9), 119 (10), 112 (100), 98 (39), 91 (14). HRMS (EI) calculated for C<sub>17</sub>H<sub>26</sub>N<sub>2</sub>O [M]<sup>+</sup>: 274.2045; found: 274.2037.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3-((<i>R</i>)-2-Methylpiperidin-1-yl)-<i>N</i>-(4-((3-((<i>S</i>)-2-methylpiperidin-1-yl)propylamino)methyl)benzyl)propan-1-amine Tetrahydrochloride (<b>11</b>(<i>S,R</i>))</h3><div class="NLM_p last">(<i>S</i>)-4-((3-(2-Methylpiperidin-1-yl)propylamino)methyl)benzaldehyde (<b>10</b>(<i>S</i>)) (0.32 g (1.14 mmol)), 0.18 g (1.44 mmol) of (<i>R</i>)-<i>N</i>-(3-aminopropyl)-2-pipecoline (<b>3</b>(<i>R</i>)), and Na<sub>2</sub>SO<sub>4</sub> were mixed in 8 mL of anhydrous MeOH, and the mixture was heated at reflux under N<sub>2</sub> atmosphere for 24 h. The solid was filtered, and the intermediate imine in MeOH was cooled to 0 °C and treated with 0.05 g (1.14 mmol) of solid NaBH<sub>4</sub>. The reaction mixture was stirred at room temperature overnight. Then water was added, and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were combined, washed with brine, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated to give 0.40 g (0.95 mmol, 83%) of <b>1</b>(<i>S,R</i>) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.30 (s, 4H, H–C2b), 3.79 (d, 4H, H–Cα), 2.89 (m, 2H, H–C1a), 2.77 (m, 2H, H–C3), 2.67 (m, 4H, H–C1), 2.41–2.27 (m, 8H, H–C3, H–C5a, H–C1a), 2.16 (m, 2H, NH), 1.75–1.48 (m, 12H, H–C2, H–C2a, H–C4a, H–C3a), 1.29 (m, 4H, H–C4a, H–C3a), 1.06 (d, 6H, <sup>3</sup><i>J</i> = 8.0 Hz, H–C6a). HRMS (CI) calculated for C<sub>26</sub>H<sub>47</sub>N<sub>4</sub> [M+1]<sup>+</sup>: 415.3801; found: 415.3803. <b>1</b>(<i>S,R</i>) was converted to the corresponding tetrahydrochloride <b>11</b>(<i>S</i>,<i>R</i>) in almost quantitative yield upon treatment with methanolic HCl in excess followed by concentration of the resulting solution. [α]<sub>D</sub> = 0.00 (<i>c</i> = 1.03, MeOH). IR (KBr) ν (cm<sup>–1</sup>): 3446, 2944, 2681, 1456, 526. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ (ppm) 7.59 (s, 4H, H–C2b), 4.33 (s, 4H, H–Cα), 3.74–3.52 (m, 2H, H–C1a), 3.42–2.98 (m, 12H, H–C1, H–C3, H–C5a, H–C1a), 2.27–1.51 (m, 16H, H–C2, H–C2a, H–C3a, H–C4a), 1.37 (d, 6H, <sup>3</sup><i>J</i> = 8.0 Hz, H–C6a). <sup>13</sup>C NMR (100.6 MHz, D<sub>2</sub>O) δ (ppm): 132.6 (C1b), 131.3 (C2b), 60.7 (C5a), 53.0 (Cα), 51.4 (C3), 50.0 (C1a), 44.8 (C1), 32.1 (C4a), 23.6 (C2a), 22.0 (C2), 20.7 (C3a), 17.8 (C6a). Anal. calculated for C<sub>26</sub>H<sub>50</sub>N<sub>4</sub>Cl<sub>4</sub>·0.5H<sub>2</sub>O: C 54.83, H 9.03, N 9.84; found: C 55.06, H 9.35, N 9.52.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Biology</h3><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">(A) Antiviral Activity</h4><div class="NLM_p last">HIV-1 strains were titered in MT-4 cells after acute infection, and infectivity was measured by evaluating the cytopathic effect that was induced after 5-day cultures as described.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Anti-HIV activity (EC<sub>50</sub>) and cytotoxicity (CC<sub>50</sub>) measurements in MT-4 cells were based on the viability of cells that had been infected or not infected with HIV-1; all were exposed to various concentrations of the test compound. After the MT-4 cells were allowed to proliferate for 5 days, the number of viable cells was quantified by a tetrazolium-based colorimetric method (MTT method) as described.</div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">(B) ADME-TOX Studies</h4><div class="NLM_p last">The multigram quantities of <b>11</b>, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) necessary for the ADME-Tox studies were prepared by ENANTIA S.L. (<a href="http://www.enantia.com" class="extLink">http://www.enantia.com</a>).</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> In Vitro Human CXCR4 Receptor Functional Assay</h3><div class="NLM_p last">This functional assay was determined at CEREP (<a href="http://www.cerep.fr" class="extLink">http://www.cerep.fr</a>). The CXCR4 (antagonist effect), test (ref. 2466), was determined using human recombinant (CHO) cells following the protocol described by Zhou et al.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Stimulant, SDF-1a; stimulant concentration, 1 nM; measured component, impedance; incubation, 28 °C; detection method, cellular dielectric spectroscopy; reference compound, MIP-II (IC<sub>50</sub> = 55 nM).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cardiac Toxicity Assays (hERG)</h3><div class="NLM_p last">Determined at CEREP (<a href="http://www.cerep.fr" class="extLink">http://www.cerep.fr</a>), hERG (automated patch-clamp) test (ref. 2245), using hERG CHO-K1 cell line by following the automated patch-clamp methodology proposed by Mathes.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Test concentration, 0.1, 1, 10 μM; incubation, 5 min/room temperature, cumulatively; detection method, automated whole-cell patch-clamp; reference, E-4031 (IC<sub>50</sub> = 25.6 nM).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Acute Intravenous Toxicity Study in Mice: Determination of Maximum Nonlethal Dose and Minimum Lethal Dose</h3><div class="NLM_p">Determined at Harlan Laboratories S.A. (<a href="http://www.harlan.com/" class="extLink">http://www.harlan.com/</a>). The acute toxicity of the test items AMD3100, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) was evaluated after their intravenous administration to Hsd:ICR (CD-1) mice (vehicle: physiological saline solution, sodium chloride 0.9%, B. Braun Medical, S.A.) followed by an observation period of 14 days. The animals received a single dose of the test item by intravenous injection in the lateral vein of the tail using a graduated syringe and a 25G (0.5 × 16 mm) needle. The test item was administered to groups consisting of two males and two females each. In the study, 4 groups consisting of 4 animals (2 males and 2 females) each were administered in physiological saline solution at doses of 1, 2, 3, 3.5, and 4 mg/kg. Viability/mortality: daily during the acclimatization period, during the first 30 min and at approximately 1, 2, 3, and 5 h after administration on test day 1 (in common with the clinical signs) and twice daily during days 2–15. Clinical signs: daily during the acclimatization period, during the first 30 min and at approximately 1, 2, 3, and 5 h after administration on test day 1, and once daily during days 2–15. All abnormalities were recorded. On the basis of the results obtained, the maximum nonlethal dose and the minimum lethal dose of the test items when administered intravenously to Hsd:ICR (CD-1) mice for both sexes as well as for males and females separately were determined.</div><div id="sec4_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">(C) Effect of CXCR4 Inhibitors on GICs and Glioma Initiation</h4></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Reagents</h3><div class="NLM_p last">CXCL12 was purchased from R&D Systems. Specific antibodies against p-MAPK, MAPK, p-AKT, AKT (all from Cell Signaling), and α-Tubulin (Sigma) were used for immunoblotting.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> GBM Neurospheres</h3><div class="NLM_p last">GBM neurospheres were generated as described previously.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Human GBM specimens were obtained from the Vall d’Hebron Hospital. The clinical protocol was approved by the Vall d’Hebron Institutional Review Board (CEIC), with informed consent obtained from all subjects.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Proliferation Assay</h3><div class="NLM_p last">Neurosphere cultures were dissociated with acutase during 3 min, and then cells were counted. An equal number of cells was seeded in triplicate for each condition and treated or left untreated with CXCR4 inhibitors (1 μM) and/or CXCL12 (10 ng/mL). Media and treatments were refreshed every 2–3 days. After 7 days cells were collected, dissociated with acutase, stained with tripan blue, and counted with a Countess Automated Cell Counter (Invitrogen).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Analysis of the CD44+ Population by Flow Cytometry</h3><div class="NLM_p last">GBM neurospheres were dissociated and individual cells were incubated for 15 min in blocking solution containing 10 μg/mL human IgG, followed by anti-CD44 antibody or the control IgG2b isotype, both FITC-conjugated (BD Pharmingen). Cells were incubated for 20 min on ice protected from light, washed in phosphate-buffered saline (PBS), and stained with propidium iodide (Sigma) to discriminate dying cells. Cells were then analyzed by flow cytometry (FACSCalibur; Beckton Dickinson) or sorted (MoFlo; DAKO) after staining with CD44-FITC.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Intracranial Tumor Assay</h3><div class="NLM_p last">All mouse experiments were approved by and performed according to the guidelines of the Institutional Animal Care Committee of the Vall d’Hebron Research Institute in agreement with the European Union and national directives. Cells were collected, dissociated with acutase, stained with trypan blue to assess viability, and counted with a Countess Automated Cell Counter (Invitrogen). Live cells (100.000) were stereotactically inoculated into the corpus striatum of the right-brain hemisphere (1 mm anterior and 1.8 mm lateral to the bregma; 2.5 mm intraparenchymal) of 9-week-old NOD-SCID mice (Charles River Laboratories). Mice were euthanized when they presented neurological symptoms or a significant loss of weight. Magnetic resonance imaging (MRI) analysis was performed in mice injected intraperitoneally with gadolinium diethylenetriamine penta-acetic acid at a dose of 0.25 mmol of gadolinium/kg of body weight. T1W magnetic resonance images were acquired in a 9.4 T vertical bore magnet interfaced to an AVANCE 400 system (Bruker) using a spin–echo sequence as described previously.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/jm300862u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Spectral data for compounds <b>6</b>(<i>S</i>), <b>6</b>(<i>R</i>), <b>3</b>(<i>S</i>), <b>3</b>(<i>R</i>), <b>1</b>(<i>S,S</i>), <b>11</b>(<i>S,S</i>), <b>1</b>(<i>R,R</i>), <b>11</b>(<i>R,R</i>), <b>9</b>(<i>S</i>), <b>10</b>(<i>S</i>), and <b>11</b>(<i>S,R</i>). High-performance liquid chromatography (HPLC) analytical profile for <b>11</b>(<i>S,S</i>), <b>11</b>(<i>R,R</i>), and <b>11</b>(<i>S,R</i>). CD44 low/CD44 null analysis. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300862u/suppl_file/jm300862u_si_001.pdf">jm300862u_si_001.pdf (2.39 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300862u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05408" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05408" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joan Seoane</span> - <span class="hlFld-Affiliation affiliation">Translational Research Program,
Vall d'Hebron Institute of Oncology (VHIO), Vall d’Hebron University
Hospital, E-08035 Barcelona, Spain and Universitat Autònoma
de Barcelona, E-08193 Cerdanyola del Vallès, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#63094d0a4d010c1111060f0f230a12104d16110f4d060716430910060c020d0623150b0a0c4d0d0617"><span class="__cf_email__" data-cfemail="e389cd8acd818c9191868f8fa38a9290cd96918fcd868796">[email protected]</span> <span class="__cf_email__" data-cfemail="026871676d636c6742746a6b6d2c6c6776">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José I. Borrell</span> - <span class="hlFld-Affiliation affiliation">Grup d’Enginyeria
Molecular,
Institut Químic de Sarrià, Universitat Ramon Llull,
Via Augusta 390, E-08017 Barcelona, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b9d397d097dbd6cbcbdcd5d5f9d0c8ca97cccbd597dcddcc99d3cadcd6d8d7dcf9cfd1d0d697d7dccd"><span class="__cf_email__" data-cfemail="543e7a3d7a363b2626313838143d25277a2126387a313021">[email protected]</span> <span class="__cf_email__" data-cfemail="1b71687e747a757e5b6d73727435757e6f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laia Ros-Blanco</span> - <span class="hlFld-Affiliation affiliation">Grup d’Enginyeria
Molecular,
Institut Químic de Sarrià, Universitat Ramon Llull,
Via Augusta 390, E-08017 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judit Anido</span> - <span class="hlFld-Affiliation affiliation">Translational Research Program,
Vall d'Hebron Institute of Oncology (VHIO), Vall d’Hebron University
Hospital, E-08035 Barcelona, Spain and Universitat Autònoma
de Barcelona, E-08193 Cerdanyola del Vallès, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramon Bosser</span> - <span class="hlFld-Affiliation affiliation">Janus Development SL, Parc Científic
Barcelona, Baldiri Reixac 10-12, E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Esté</span> - <span class="hlFld-Affiliation affiliation">IrsiCaixa, Hospital Universitari
Germans Trias i Pujol, Universitat Autònoma de Barcelona, E-08916
Badalona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bonaventura Clotet</span> - <span class="hlFld-Affiliation affiliation">IrsiCaixa, Hospital Universitari
Germans Trias i Pujol, Universitat Autònoma de Barcelona, E-08916
Badalona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Kosoy</span> - <span class="hlFld-Affiliation affiliation">Janus Development SL, Parc Científic
Barcelona, Baldiri Reixac 10-12, E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luis Ruíz-Ávila</span> - <span class="hlFld-Affiliation affiliation">Janus Development SL, Parc Científic
Barcelona, Baldiri Reixac 10-12, E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jordi Teixidó</span> - <span class="hlFld-Affiliation affiliation">Grup d’Enginyeria
Molecular,
Institut Químic de Sarrià, Universitat Ramon Llull,
Via Augusta 390, E-08017 Barcelona, Spain</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare the following competing financial interest(s): L. Ros-Blanco, J. Esté, J. Teixidó, and J. I. Borrell are co-inventors of patents WO 2008/049950 A1 and PCT/ES2011/070407 covering the compounds and their use, licensed to Janus Development SL.<br /></br></p></li></ul></div><div class="ack" id="ACK-d3358e3121-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors appreciate the financial support from Janus Development SL, which also contributed to the ADME-TOX and GICs/glioma initiation studies design. We also appreciate the financial support from the Spanish Ministerio de Economı́a y Competitividad project SAF2010-C21617-C02 (J.I.B. and B.C.) and BFU2009-06958 (J.A.E.). L.R.-B. thanks IQS and Generalitat de Catalunya for a scholarship and a FI–B 2008–2010 scholarship, respectively.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i38" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i38"> Abbreviations Used</h2><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">CC<sub>50</sub></td><td class="NLM_def"><p class="first last">half cytotoxic concentration</p></td></tr><tr><td class="NLM_term">CXCL12</td><td class="NLM_def"><p class="first last">chemokine (C–X–C motif) ligand 12</p></td></tr><tr><td class="NLM_term">CXCR4</td><td class="NLM_def"><p class="first last">CXC chemokine receptor type 4</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% effective concentration</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">grade IV gliomas or glioblastoma</p></td></tr><tr><td class="NLM_term">GICs</td><td class="NLM_def"><p class="first last">glioma initiating cells</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human Ether-à-go-go-Related Gene</p></td></tr><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MLD</td><td class="NLM_def"><p class="first last">minimum lethal dose</p></td></tr><tr><td class="NLM_term">MND</td><td class="NLM_def"><p class="first last">maximum nonlethal dose</p></td></tr><tr><td class="NLM_term">MRI</td><td class="NLM_def"><p class="first last">magnetic resonance imaging</p></td></tr><tr><td class="NLM_term">p-Akt</td><td class="NLM_def"><p class="first last">phospho-Akt</p></td></tr><tr><td class="NLM_term">p-MAPK</td><td class="NLM_def"><p class="first last">phospho-MAPK</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Brat, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellano-Sanchez, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devi, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Meir, E. G.</span><span> </span><span class="NLM_article-title">Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">920</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=920-927&author=D.+J.+Bratauthor=A.+A.+Castellano-Sanchezauthor=S.+B.+Hunterauthor=M.+Pecotauthor=C.+Cohenauthor=E.+H.+Hammondauthor=S.+N.+Deviauthor=B.+Kaurauthor=E.+G.+Van+Meir&title=Pseudopalisades+in+Glioblastoma+Are+Hypoxic%2C+Express+Extracellular+Matrix+Proteases%2C+and+Are+Formed+by+an+Actively+Migrating+Cell+Population"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrat%26aufirst%3DD.%2BJ.%26aulast%3DCastellano-Sanchez%26aufirst%3DA.%2BA.%26aulast%3DHunter%26aufirst%3DS.%2BB.%26aulast%3DPecot%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DC.%26aulast%3DHammond%26aufirst%3DE.%2BH.%26aulast%3DDevi%26aufirst%3DS.%2BN.%26aulast%3DKaur%26aufirst%3DB.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26atitle%3DPseudopalisades%2520in%2520Glioblastoma%2520Are%2520Hypoxic%252C%2520Express%2520Extracellular%2520Matrix%2520Proteases%252C%2520and%2520Are%2520Formed%2520by%2520an%2520Actively%2520Migrating%2520Cell%2520Population%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D920%26epage%3D927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Furnari, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachoo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukasa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stommel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinho, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavenee, W. K.</span><span> </span><span class="NLM_article-title">Malignant astrocytic glioma: Genetics, biology, and paths to treatment</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2683</span><span class="NLM_x">–</span> <span class="NLM_lpage">2710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1101%2Fgad.1596707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=17974913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2683-2710&author=F.+B.+Furnariauthor=T.+Fentonauthor=R.+M.+Bachooauthor=A.+Mukasaauthor=J.+M.+Stommelauthor=A.+Steghauthor=W.+C.+Hahnauthor=K.+L.+Ligonauthor=D.+N.+Louisauthor=C.+Brennanauthor=L.+Chinauthor=R.+A.+DePinhoauthor=W.+K.+Cavenee&title=Malignant+astrocytic+glioma%3A+Genetics%2C+biology%2C+and+paths+to+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Malignant astrocytic glioma: genetics, biology, and paths to treatment</span></div><div class="casAuthors">Furnari, Frank B.; Fenton, Tim; Bachoo, Robert M.; Mukasa, Akitake; Stommel, Jayne M.; Stegh, Alexander; Hahn, William C.; Ligon, Keith L.; Louis, David N.; Brennan, Cameron; Chin, Lynda; DePinho, Ronald A.; Cavenee, Webster K.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2683-2710</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Malignant astrocytic gliomas such as glioblastoma are the most common and lethal intracranial tumors.  These cancers exhibit a relentless malignant progression characterized by widespread invasion throughout the brain, resistance to traditional and newer targeted therapeutic approaches, destruction of normal brain tissue, and certain death.  The recent confluence of advances in stem cell biol., cell signaling, genome and computational science and genetic model systems have revolutionized our understanding of the mechanisms underlying the genetics, biol. and clin. behavior of glioblastoma.  This progress is fueling new opportunities for understanding the fundamental basis for development of this devastating disease and also novel therapies that, for the first time, portend meaningful clin. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDlfTN9OqeLLVg90H21EOLACvtfcHk0lhm3puafzOAZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitLrO&md5=5b89b311117f70e3708194afa9165414</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fgad.1596707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1596707%26sid%3Dliteratum%253Aachs%26aulast%3DFurnari%26aufirst%3DF.%2BB.%26aulast%3DFenton%26aufirst%3DT.%26aulast%3DBachoo%26aufirst%3DR.%2BM.%26aulast%3DMukasa%26aufirst%3DA.%26aulast%3DStommel%26aufirst%3DJ.%2BM.%26aulast%3DStegh%26aufirst%3DA.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DLigon%26aufirst%3DK.%2BL.%26aulast%3DLouis%26aufirst%3DD.%2BN.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26atitle%3DMalignant%2520astrocytic%2520glioma%253A%2520Genetics%252C%2520biology%252C%2520and%2520paths%2520to%2520treatment%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26spage%3D2683%26epage%3D2710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parada, L. F.</span><span> </span><span class="NLM_article-title">The molecular and genetic basis of neurological tumours</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1038%2Fnrc866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=12154354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslGqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=616-626&author=Y.+Zhuauthor=L.+F.+Parada&title=The+molecular+and+genetic+basis+of+neurological+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular and Genetic Basis of Neurological Tumours</span></div><div class="casAuthors">Zhu, Yuan; Parada, Luis F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">616-626</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There are no effective therapies for many tumors of the nervous system.  This is, in part, a consequence of their location within relatively inaccessible tissues.  It is also likely, however, that the unique characteristics of the cells that give rise to these tumors create a set of conditions that facilitate tumor development.  Here, the authors consider recent advances in mol. genetics, the development of mouse models and developmental neurobiol. as they relate to tumors of neuroectodermal origin.  It is likely that these advances will provide insight into underlying mechanisms and provide a rational framework for the development of effective interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpW4IsUYen4rVg90H21EOLACvtfcHk0lhm3puafzOAZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslGqsL0%253D&md5=53ac48227dbcaf7421994089dcdb6664</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc866%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DParada%26aufirst%3DL.%2BF.%26atitle%3DThe%2520molecular%2520and%2520genetic%2520basis%2520of%2520neurological%2520tumours%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D616%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Anido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sáez-Borderías, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzàlez-Juncà, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodón, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmona, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto-Sánchez, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barba, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Sáez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudkin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuartas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raventós, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Ricarte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poca, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Dorado, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahn, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yingling, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodón, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahuquillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seoane, J.</span><span> </span><span class="NLM_article-title">TGF-beta Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=655-668&author=J.+Anidoauthor=A.+S%C3%A1ez-Border%C3%ADasauthor=A.+Gonz%C3%A0lez-Junc%C3%A0author=L.+Rod%C3%B3nauthor=G.+Folchauthor=M.+A.+Carmonaauthor=R.+M.+Prieto-S%C3%A1nchezauthor=I.+Barbaauthor=E.+Mart%C3%ADnez-S%C3%A1ezauthor=L.+Prudkinauthor=I.+Cuartasauthor=C.+Ravent%C3%B3sauthor=F.+Mart%C3%ADnez-Ricarteauthor=M.+A.+Pocaauthor=D.+Garc%C3%ADa-Doradoauthor=M.+M.+Lahnauthor=J.+M.+Yinglingauthor=J.+Rod%C3%B3nauthor=J.+Sahuquilloauthor=J.+Baselgaauthor=J.+Seoane&title=TGF-beta+Receptor+Inhibitors+Target+the+CD44%28high%29%2FId1%28high%29+Glioma-Initiating+Cell+Population+in+Human+Glioblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnido%26aufirst%3DJ.%26aulast%3DS%25C3%25A1ez-Border%25C3%25ADas%26aufirst%3DA.%26aulast%3DGonz%25C3%25A0lez-Junc%25C3%25A0%26aufirst%3DA.%26aulast%3DRod%25C3%25B3n%26aufirst%3DL.%26aulast%3DFolch%26aufirst%3DG.%26aulast%3DCarmona%26aufirst%3DM.%2BA.%26aulast%3DPrieto-S%25C3%25A1nchez%26aufirst%3DR.%2BM.%26aulast%3DBarba%26aufirst%3DI.%26aulast%3DMart%25C3%25ADnez-S%25C3%25A1ez%26aufirst%3DE.%26aulast%3DPrudkin%26aufirst%3DL.%26aulast%3DCuartas%26aufirst%3DI.%26aulast%3DRavent%25C3%25B3s%26aufirst%3DC.%26aulast%3DMart%25C3%25ADnez-Ricarte%26aufirst%3DF.%26aulast%3DPoca%26aufirst%3DM.%2BA.%26aulast%3DGarc%25C3%25ADa-Dorado%26aufirst%3DD.%26aulast%3DLahn%26aufirst%3DM.%2BM.%26aulast%3DYingling%26aufirst%3DJ.%2BM.%26aulast%3DRod%25C3%25B3n%26aufirst%3DJ.%26aulast%3DSahuquillo%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DSeoane%26aufirst%3DJ.%26atitle%3DTGF-beta%2520Receptor%2520Inhibitors%2520Target%2520the%2520CD44%2528high%2529%252FId1%2528high%2529%2520Glioma-Initiating%2520Cell%2520Population%2520in%2520Human%2520Glioblastoma%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D655%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Visvader, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, G. J.</span><span> </span><span class="NLM_article-title">Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1038%2Fnrc2499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=18784658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=755-768&author=J.+E.+Visvaderauthor=G.+J.+Lindeman&title=Cancer+stem+cells+in+solid+tumours%3A+Accumulating+evidence+and+unresolved+questions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer stem cells in solid tumors: accumulating evidence and unresolved questions</span></div><div class="casAuthors">Visvader, Jane E.; Lindeman, Geoffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">755-768</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review article, the authors discuss the evidence supporting the existence of CSCs in solid tumors.  Solid tumors are an enormous cancer burden and a major therapeutic challenge.  The cancer stem cell (CSC) hypothesis provides an attractive cellular mechanism to account for the therapeutic refractoriness and dormant behavior exhibited by many of these tumors.  There is increasing evidence that diverse solid tumors are hierarchically organized and sustained by a distinct subpopulation of CSCs.  Direct evidence for the CSC hypothesis has recently emerged from mouse models of epithelial tumorigenesis, although alternative models of heterogeneity also seem to apply.  The clin. relevance of CSCs remains a fundamental issue but preliminary findings indicate that specific targeting may be possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBOh-v2SBeBbVg90H21EOLACvtfcHk0lhm3puafzOAZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtb3K&md5=7374ce009670073b88ad284dfeacbec3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc2499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2499%26sid%3Dliteratum%253Aachs%26aulast%3DVisvader%26aufirst%3DJ.%2BE.%26aulast%3DLindeman%26aufirst%3DG.%2BJ.%26atitle%3DCancer%2520stem%2520cells%2520in%2520solid%2520tumours%253A%2520Accumulating%2520evidence%2520and%2520unresolved%2520questions%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D755%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Este, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telenti, A.</span><span> </span><span class="NLM_article-title">HIV entry inhibitors</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=81-88&author=J.+A.+Esteauthor=A.+Telenti&title=HIV+entry+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEste%26aufirst%3DJ.%2BA.%26aulast%3DTelenti%26aufirst%3DA.%26atitle%3DHIV%2520entry%2520inhibitors%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26spage%3D81%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Tilton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doms, R. W.</span><span> </span><span class="NLM_article-title">Entry inhibitors in the treatment of HIV-1 infection</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=91-100&author=J.+C.+Tiltonauthor=R.+W.+Doms&title=Entry+inhibitors+in+the+treatment+of+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTilton%26aufirst%3DJ.%2BC.%26aulast%3DDoms%26aufirst%3DR.%2BW.%26atitle%3DEntry%2520inhibitors%2520in%2520the%2520treatment%2520of%2520HIV-1%2520infection%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D85%26spage%3D91%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Pettersson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Nueno, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ros-Blanco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puig de La Bellacasa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabal, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batllori, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet-Codina, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armand-Ugón, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esté, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixidó, J.</span><span> </span><span class="NLM_article-title">Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1549-1557&author=S.+Petterssonauthor=V.+I.+P%C3%A9rez-Nuenoauthor=L.+Ros-Blancoauthor=R.+Puig+de+La+Bellacasaauthor=M.+O.+Rabalauthor=X.+Batlloriauthor=B.+Clotetauthor=I.+Clotet-Codinaauthor=M.+Armand-Ug%C3%B3nauthor=J.+A.+Est%C3%A9author=J.+I.+Borrellauthor=J.+Teixid%C3%B3&title=Discovery+of+novel+non-cyclam+polynitrogenated+CXCR4+coreceptor+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DS.%26aulast%3DP%25C3%25A9rez-Nueno%26aufirst%3DV.%2BI.%26aulast%3DRos-Blanco%26aufirst%3DL.%26aulast%3DPuig%2Bde%2BLa%2BBellacasa%26aufirst%3DR.%26aulast%3DRabal%26aufirst%3DM.%2BO.%26aulast%3DBatllori%26aufirst%3DX.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DClotet-Codina%26aufirst%3DI.%26aulast%3DArmand-Ug%25C3%25B3n%26aufirst%3DM.%26aulast%3DEst%25C3%25A9%26aufirst%3DJ.%2BA.%26aulast%3DBorrell%26aufirst%3DJ.%2BI.%26aulast%3DTeixid%25C3%25B3%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520novel%2520non-cyclam%2520polynitrogenated%2520CXCR4%2520coreceptor%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1549%26epage%3D1557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bian, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ping, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. M.</span><span> </span><span class="NLM_article-title">Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival</span> <span class="citation_source-journal">Neurosurgery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">570</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=570-578&author=X.+W.+Bianauthor=S.+X.+Yangauthor=J.+H.+Chenauthor=Y.+F.+Pingauthor=X.+D.+Zhouauthor=Q.+L.+Wangauthor=X.+F.+Jiangauthor=W.+Gongauthor=H.+L.+Xiaoauthor=L.+L.+Duauthor=Z.+Q.+Chenauthor=W.+Zhaoauthor=J.+Q.+Shiauthor=J.+M.+Wang&title=Preferential+expression+of+chemokine+receptor+CXCR4+by+highly+malignant+human+gliomas+and+its+association+with+poor+patient+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DX.%2BW.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DPing%26aufirst%3DY.%2BF.%26aulast%3DZhou%26aufirst%3DX.%2BD.%26aulast%3DWang%26aufirst%3DQ.%2BL.%26aulast%3DJiang%26aufirst%3DX.%2BF.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DH.%2BL.%26aulast%3DDu%26aufirst%3DL.%2BL.%26aulast%3DChen%26aufirst%3DZ.%2BQ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DJ.%2BQ.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26atitle%3DPreferential%2520expression%2520of%2520chemokine%2520receptor%2520CXCR4%2520by%2520highly%2520malignant%2520human%2520gliomas%2520and%2520its%2520association%2520with%2520poor%2520patient%2520survival%26jtitle%3DNeurosurgery%26date%3D2007%26volume%3D61%26spage%3D570%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Tseng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasquez-Medrano, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. M.</span><span> </span><span class="NLM_article-title">Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1805</span><span class="NLM_x">–</span> <span class="NLM_lpage">1809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1038%2Fbjc.2011.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=21587260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntV2hsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2011&pages=1805-1809&author=D.+Tsengauthor=D.+A.+Vasquez-Medranoauthor=J.+M.+Brown&title=Targeting+SDF-1%2FCXCR4+to+inhibit+tumour+vasculature+for+treatment+of+glioblastomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting SDF-1/CXCR4 to inhibit tumor vasculature for treatment of glioblastomas</span></div><div class="casAuthors">Tseng, D.; Vasquez-Medrano, D. A.; Brown, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1805-1809</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Local recurrence of glioblastomas is a major cause of patient mortality after definitive treatment.  This review discusses the roles of the chemokine stromal cell-derived factor-1 and its receptor CXC chemokine receptor 4 (CXCR4) in affecting the sensitivity of glioblastomas to irradn.  Blocking these mols. prevents or delays tumor recurrence after irradn. by inhibiting the recruitment of CD11b+ monocytes/macrophages that participate in revascularising the tumor.  We review the literature pertaining to the mechanism by which revascularisation occurs following tumor irradn. using exptl. models.  Areas of interest and debate in the literature include the process by which endothelial cells die after irradn. and the identity/origin of the cells that reconstitute the tumor blood vessels after injury.  Understanding the processes that mediate tumor revascularisation will guide the improvement of clin. strategies for preventing recurrence of glioblastoma after irradn.  British Journal of Cancer (2011) 104, 1805-1809; doi:10.1038/bjc.2011.169 www.bjcancer.com Published online 17 May 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ey-Qxw4cYLVg90H21EOLACvtfcHk0lgFMje7c3Evkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntV2hsb8%253D&md5=7f65a9048f936b80a79b39686dc0c54f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2011.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2011.169%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DD.%26aulast%3DVasquez-Medrano%26aufirst%3DD.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26atitle%3DTargeting%2520SDF-1%252FCXCR4%2520to%2520inhibit%2520tumour%2520vasculature%2520for%2520treatment%2520of%2520glioblastomas%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2011%26volume%3D104%26spage%3D1805%26epage%3D1809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Teicher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S. P.</span><span> </span><span class="NLM_article-title">CXCL12 (SDF-1)/CXCR4 pathway in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1158%2F1078-0432.CCR-09-2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=20484021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXms1Ojs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2927-2931&author=B.+A.+Teicherauthor=S.+P.+Fricker&title=CXCL12+%28SDF-1%29%2FCXCR4+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12 (SDF-1)/CXCR4 Pathway in Cancer</span></div><div class="casAuthors">Teicher, Beverly A.; Fricker, Simon P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2927-2931</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Chemokines, small proinflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion.  The chemokine CXCL12 [stromal cell-derived factor-1 (SDF-1)] binds primarily to CXC receptor 4 (CXCR4; CD184).  The binding of CXCL12 to CXCR4 induces intracellular signaling through several divergent pathways initiating signals related to chemotaxis, cell survival and/or proliferation, increase in intracellular calcium, and gene transcription.  CXCR4 is expressed on multiple cell types including lymphocytes, hematopoietic stem cells, endothelial and epithelial cells, and cancer cells.  The CXCL12/CXCR4 axis is involved in tumor progression, angiogenesis, metastasis, and survival.  This pathway is a target for therapeutics that can block the CXCL12/CXCR4 interaction or inhibit downstream intracellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosuc1QGMW7LbVg90H21EOLACvtfcHk0lgFMje7c3Evkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXms1Ojs7o%253D&md5=ac1e120fac46488d6f8bb1fc7c6741c2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-2329%26sid%3Dliteratum%253Aachs%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DCXCL12%2520%2528SDF-1%2529%252FCXCR4%2520pathway%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D2927%26epage%3D2931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Terasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemori, M.</span><span> </span><span class="NLM_article-title">CXCL12/CXCR4 signaling in malignant brain tumors: A potential pharmacological therapeutic target</span> <span class="citation_source-journal">Brain Tumor Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1007%2Fs10014-010-0013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=21210239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGjs73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=89-97&author=M.+Terasakiauthor=Y.+Sugitaauthor=F.+Arakawaauthor=Y.+Okadaauthor=K.+Ohshimaauthor=M.+Shigemori&title=CXCL12%2FCXCR4+signaling+in+malignant+brain+tumors%3A+A+potential+pharmacological+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target</span></div><div class="casAuthors">Terasaki, Mizuhiko; Sugita, Yasuo; Arakawa, Fumiko; Okada, Yosuke; Ohshima, Koichi; Shigemori, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Brain Tumor Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">BTPAFM</span>;
        ISSN:<span class="NLM_cas:issn">1433-7398</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">A review.  Chemokines are 8- to 12-kDa peptides that function as chemoattractant cytokines involved in cell activation, differentiation, and trafficking.  Chemokines bind to specific G-protein-coupled, seven-span transmembrane receptors on the plasma membrane of target cells.  Chemokine (C-X-C motif) ligand 12 (CXCL12), an alpha-chemokine that binds to G-protein-coupled chemokine (C-X-C motif) receptor 4 (CXCR4), plays an important and unique role in the regulation of stem/progenitor-cell trafficking.  As CXCR4 is expressed on several cancer cells, these CXCR4-pos. cancer cells may metastasize to organs that secrete/express CXCL12.  Regarding brain tumors, recent data demonstrate that glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via the CXCL12/CXCR4 pathway.  In addn., CXCL12/CXCR4 have recently been shown to be expressed in primary central nervous system (PCNS) lymphomas, and a role for chemokines in the pathogenesis of PCNS lymphomas was suggested.  This review focuses on current knowledge regarding the biol. of the CXCL12/CXCR4 pathway in the context of understanding their potential role in malignant gliomas and PCNS lymphoma development.  The CXCL12/CXCR4 interaction as a therapeutic target for malignant brain tumors is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvY1lkFur35rVg90H21EOLACvtfcHk0lgFMje7c3Evkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGjs73F&md5=c5bc15e1589f607e7480f0e769fda7a0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs10014-010-0013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10014-010-0013-1%26sid%3Dliteratum%253Aachs%26aulast%3DTerasaki%26aufirst%3DM.%26aulast%3DSugita%26aufirst%3DY.%26aulast%3DArakawa%26aufirst%3DF.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DOhshima%26aufirst%3DK.%26aulast%3DShigemori%26aufirst%3DM.%26atitle%3DCXCL12%252FCXCR4%2520signaling%2520in%2520malignant%2520brain%2520tumors%253A%2520A%2520potential%2520pharmacological%2520therapeutic%2520target%26jtitle%3DBrain%2520Tumor%2520Pathol.%26date%3D2011%26volume%3D28%26spage%3D89%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">do Carmo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalheiro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, M. C.</span><span> </span><span class="NLM_article-title">CXCL12/CXCR4 promotes motility and proliferation of glioma cells</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.4161%2Fcbt.9.1.10342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=19923906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Wjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=56-65&author=A.+do+Carmoauthor=I.+Patricioauthor=M.+T.+Cruzauthor=H.+Carvalheiroauthor=C.+R.+Oliveiraauthor=M.+C.+Lopes&title=CXCL12%2FCXCR4+promotes+motility+and+proliferation+of+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12/CXCR4 promotes motility and proliferation of glioma cells</span></div><div class="casAuthors">do Carmo, Analia; Patricio, Ines; Cruz, Maria T.; Carvalheiro, Helena; Oliveira, Catarina R.; Lopes, Maria C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-65</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is the most aggressive and malignant brain tumor.  Recent studies indicated that glioma samples are characterized by increased expression of CXCR4, the CXCL12/SDF-1 chemokine receptor.  To better understand the role of CXCR4 in GBM biol. we performed an integrated study where we simultaneously evaluate the contribution of the CXCR4/CXCL12 signaling pathway to the proliferation, survival and motility of a human GBM cell line.  Our results indicated that CXCR4/CXCL12 axis induced an increase in cell proliferation and in cell motility.  The blockage of CXCR4 induced a significant increase of apoptosis.  Together, our results indicated that CXCR4/CXCL12 signalling pathway may contribute to GBM development and emphasize the therapeutic potential of this pathway in patients with GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkyHcwVCIEWbVg90H21EOLACvtfcHk0lgFMje7c3Evkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Wjt7Y%253D&md5=0c78d3de5d3e72ccae5f42cb064bf27f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4161%2Fcbt.9.1.10342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.9.1.10342%26sid%3Dliteratum%253Aachs%26aulast%3Ddo%2BCarmo%26aufirst%3DA.%26aulast%3DPatricio%26aufirst%3DI.%26aulast%3DCruz%26aufirst%3DM.%2BT.%26aulast%3DCarvalheiro%26aufirst%3DH.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26aulast%3DLopes%26aufirst%3DM.%2BC.%26atitle%3DCXCL12%252FCXCR4%2520promotes%2520motility%2520and%2520proliferation%2520of%2520glioma%2520cells%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D56%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Peñuelas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto-Sánchez, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barba, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuartas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Dorado, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poca, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahuquillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seoane, J.</span><span> </span><span class="NLM_article-title">TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma</span> <span class="citation_source-journal">Cancer Cell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=315-327&issue=4&author=S.+Pe%C3%B1uelasauthor=J.+Anidoauthor=R.+M.+Prieto-S%C3%A1nchezauthor=G.+Folchauthor=I.+Barbaauthor=I.+Cuartasauthor=D.+Garc%C3%ADa-Doradoauthor=M.+A.+Pocaauthor=J.+Sahuquilloauthor=J.+Baselgaauthor=J.+Seoane&title=TGF-beta+increases+glioma-initiating+cell+self-renewal+through+the+induction+of+LIF+in+human+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25C3%25B1uelas%26aufirst%3DS.%26aulast%3DAnido%26aufirst%3DJ.%26aulast%3DPrieto-S%25C3%25A1nchez%26aufirst%3DR.%2BM.%26aulast%3DFolch%26aufirst%3DG.%26aulast%3DBarba%26aufirst%3DI.%26aulast%3DCuartas%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Dorado%26aufirst%3DD.%26aulast%3DPoca%26aufirst%3DM.%2BA.%26aulast%3DSahuquillo%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DSeoane%26aufirst%3DJ.%26atitle%3DTGF-beta%2520increases%2520glioma-initiating%2520cell%2520self-renewal%2520through%2520the%2520induction%2520of%2520LIF%2520in%2520human%2520glioblastoma%26jtitle%3DCancer%2520Cell.%26date%3D2009%26volume%3D15%26issue%3D4%26spage%3D315%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span> </span><span class="NLM_article-title">A practical preparation of (<i>R</i>)- and (<i>S</i>)-<i>N</i>-Boc-2-methylpiperidines</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=1275-1278&author=D.+Dollerauthor=R.+Daviesauthor=S.+Chackalamannil&title=A+practical+preparation+of+%28R%29-+and+%28S%29-N-Boc-2-methylpiperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DChackalamannil%26aufirst%3DS.%26atitle%3DA%2520practical%2520preparation%2520of%2520%2528R%2529-%2520and%2520%2528S%2529-N-Boc-2-methylpiperidines%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1997%26volume%3D8%26spage%3D1275%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Apelt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertz, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Development of a new class of nonimidazole histamine H<sub>3</sub> receptor ligands with combined inhibitory histamine <i>N</i>-methyltransferase activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0110845" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1128-1141&author=J.+Apeltauthor=X.+Ligneauauthor=H.+H.+Pertzauthor=J.+Arrangauthor=C.+R.+Ganellinauthor=J.+Schwartzauthor=W.+Schunackauthor=H.+Stark&title=Development+of+a+new+class+of+nonimidazole+histamine+H3+receptor+ligands+with+combined+inhibitory+histamine+N-methyltransferase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm0110845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0110845%26sid%3Dliteratum%253Aachs%26aulast%3DApelt%26aufirst%3DJ.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DPertz%26aufirst%3DH.%2BH.%26aulast%3DArrang%26aufirst%3DJ.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DJ.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520a%2520new%2520class%2520of%2520nonimidazole%2520histamine%2520H3%2520receptor%2520ligands%2520with%2520combined%2520inhibitory%2520histamine%2520N-methyltransferase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1128%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jo, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pae, A. N.</span><span> </span><span class="NLM_article-title">Novel T-type calcium channel blockers: Dioxoquinazoline carboxamide derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=365-373&author=M.+N.+Joauthor=H.+J.+Seoauthor=Y.+Kimauthor=S.+H.+Seoauthor=H.+Rhimauthor=Y.+S.+Choauthor=J.+H.+Chaauthor=H.+Y.+Kohauthor=H.+Chooauthor=A.+N.+Pae&title=Novel+T-type+calcium+channel+blockers%3A+Dioxoquinazoline+carboxamide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DM.%2BN.%26aulast%3DSeo%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DSeo%26aufirst%3DS.%2BH.%26aulast%3DRhim%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DCha%26aufirst%3DJ.%2BH.%26aulast%3DKoh%26aufirst%3DH.%2BY.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DPae%26aufirst%3DA.%2BN.%26atitle%3DNovel%2520T-type%2520calcium%2520channel%2520blockers%253A%2520Dioxoquinazoline%2520carboxamide%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D365%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, V. W.</span><span> </span><span class="NLM_article-title">CXCR4 is a major chemokine receptor on glioma cells and mediates their survival</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">49481</span><span class="NLM_x">–</span> <span class="NLM_lpage">49487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=49481-49487&author=Y.+Zhouauthor=P.+H.+Larsenauthor=Ch.+Haoauthor=V.+W.+Yong&title=CXCR4+is+a+major+chemokine+receptor+on+glioma+cells+and+mediates+their+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26aulast%3DHao%26aufirst%3DCh.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DCXCR4%2520is%2520a%2520major%2520chemokine%2520receptor%2520on%2520glioma%2520cells%2520and%2520mediates%2520their%2520survival%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D49481%26epage%3D49487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mathes, C.</span><span> </span><span class="NLM_article-title">QPatch: The past, present and future of automated patch clamp</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1517%2F14728222.10.2.319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=16548779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVOmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=319-327&author=C.+Mathes&title=QPatch%3A+The+past%2C+present+and+future+of+automated+patch+clamp"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">QPatch: the past, present and future of automated patch clamp</span></div><div class="casAuthors">Mathes, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-327</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The QPatch 16 significantly increases throughput for gigaseal patch clamp expts., making direct measurements in ion channel drug discovery and safety testing feasible.  Released to the market in the Autumn of 2004 by Sophion Bioscience, the QPatch originated from work done at NeuroSearch (Denmark) in the early days of automated patch clamp.  Today, the QPatch provides many unique features.  For example, only the QPatch includes an automated cell prepn. station making several hours of unattended operation possible.  The 16-channel electrode array, called the QPlate, includes glass-coated microfluidic channels for less compd. absorption and, hence, more accurate IC50 values.  The microfluidic pathways also allow for very small amts. of compd. used for each expt. (∼ 5 μl per addn.).  Only the QPatch has four independent pipetting heads for more efficient liq. handling (esp. for ligand-gated ion channel expts.).  Patch clamp recordings with the QPatch match the high quality of conventional patch clamp and in some cases the results are even better.  For example, only the QPatch includes 100% series resistance compensation for the elimination of false positives due to voltage errors.  Finally, the modular QPatch 16 was designed with more channels in mind.  The upgrade pathway to 48-channels (the QPatch HT) will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqywPZMP8PNwrVg90H21EOLACvtfcHk0ljfJbRYZtw30A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVOmt7k%253D&md5=7dcd02a69652955e261f6928fbb76b81</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.2.319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.2.319%26sid%3Dliteratum%253Aachs%26aulast%3DMathes%26aufirst%3DC.%26atitle%3DQPatch%253A%2520The%2520past%252C%2520present%2520and%2520future%2520of%2520automated%2520patch%2520clamp%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D319%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sturgill, T. W.</span><span> </span><span class="NLM_article-title">MAP kinase: It’s been longer than fifteen minutes</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2008&pages=1-4&author=T.+W.+Sturgill&title=MAP+kinase%3A+It%E2%80%99s+been+longer+than+fifteen+minutes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSturgill%26aufirst%3DT.%2BW.%26atitle%3DMAP%2520kinase%253A%2520It%25E2%2580%2599s%2520been%2520longer%2520than%2520fifteen%2520minutes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D371%26spage%3D1%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Rubin, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieran, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, R. A.</span><span> </span><span class="NLM_article-title">A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">13513</span><span class="NLM_x">–</span> <span class="NLM_lpage">13518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13513-13518&issue=23&author=J.+B.+Rubinauthor=A.+L.+Kungauthor=R.+S.+Kleinauthor=J.+A.+Chanauthor=Y.+Sunauthor=K.+Schmidtauthor=M.+W.+Kieranauthor=A.+D.+Lusterauthor=R.+A.+Segal&title=A+small-molecule+antagonist+of+CXCR4+inhibits+intracranial+growth+of+primary+brain+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DJ.%2BB.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520CXCR4%2520inhibits%2520intracranial%2520growth%2520of%2520primary%2520brain%2520tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26issue%3D23%26spage%3D13513%26epage%3D13518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Gonzalez-Ortega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Este, J. A.</span><span> </span><span class="NLM_article-title">Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2011&pages=479-483&author=E.+Gonzalez-Ortegaauthor=E.+Ballanaauthor=R.+Badiaauthor=B.+Clotetauthor=J.+A.+Este&title=Compensatory+mutations+rescue+the+virus+replicative+capacity+of+VIRIP-resistant+HIV-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Ortega%26aufirst%3DE.%26aulast%3DBallana%26aufirst%3DE.%26aulast%3DBadia%26aufirst%3DR.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DEste%26aufirst%3DJ.%2BA.%26atitle%3DCompensatory%2520mutations%2520rescue%2520the%2520virus%2520replicative%2520capacity%2520of%2520VIRIP-resistant%2520HIV-1%26jtitle%3DAntiviral%2520Res.%26date%3D2011%26volume%3D92%26spage%3D479%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salvatore  Di Maro</span>, <span class="hlFld-ContribAuthor ">Francesco Saverio  Di Leva</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Trotta</span>, <span class="hlFld-ContribAuthor ">Diego  Brancaccio</span>, <span class="hlFld-ContribAuthor ">Luigi  Portella</span>, <span class="hlFld-ContribAuthor ">Michela  Aurilio</span>, <span class="hlFld-ContribAuthor ">Stefano  Tomassi</span>, <span class="hlFld-ContribAuthor ">Anna  Messere</span>, <span class="hlFld-ContribAuthor ">Deborah  Sementa</span>, <span class="hlFld-ContribAuthor ">Secondo  Lastoria</span>, <span class="hlFld-ContribAuthor ">Alfonso  Carotenuto</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Stefania  Scala</span>, and <span class="hlFld-ContribAuthor ">Luciana  Marinelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9641-9652. <a href="https://doi.org/10.1021/acs.jmedchem.7b01062" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01062%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BBiological%252BCharacterization%252Bof%252Ba%252BNovel%25252C%252BPotent%25252C%252Band%252BSerum%252BStable%252BC-X-C%252BChemokine%252BReceptor%252BType%252B4%252B%252528CXCR4%252529%252BAntagonist%26aulast%3DDi%2BMaro%26aufirst%3DSalvatore%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D24072017%26date%3D20112017%26date%3D14122017%26date%3D10112017%26volume%3D60%26issue%3D23%26spage%3D9641%26epage%3D9652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiong  Fang</span>, <span class="hlFld-ContribAuthor ">Qian  Meng</span>, <span class="hlFld-ContribAuthor ">Huijun  Zhang</span>, <span class="hlFld-ContribAuthor ">Boqiang  Liang</span>, <span class="hlFld-ContribAuthor ">Siyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Chaozai  Zhang</span>, <span class="hlFld-ContribAuthor ">Lina S.  Huang</span>, <span class="hlFld-ContribAuthor ">Xingquan  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert T.  Schooley</span>, <span class="hlFld-ContribAuthor ">Jing  An</span>, <span class="hlFld-ContribAuthor ">Yan  Xu</span>, <span class="hlFld-ContribAuthor ">Ziwei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological characterization of a new class of symmetrical polyamine-based small molecule CXCR4 antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112410. <a href="https://doi.org/10.1016/j.ejmech.2020.112410" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112410%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bcharacterization%252Bof%252Ba%252Bnew%252Bclass%252Bof%252Bsymmetrical%252Bpolyamine-based%252Bsmall%252Bmolecule%252BCXCR4%252Bantagonists%26aulast%3DFang%26aufirst%3DXiong%26date%3D2020%26volume%3D200%26spage%3D112410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.  Adlere</span>, <span class="hlFld-ContribAuthor ">S.  Sun</span>, <span class="hlFld-ContribAuthor ">A.  Zarca</span>, <span class="hlFld-ContribAuthor ">L.  Roumen</span>, <span class="hlFld-ContribAuthor ">M.  Gozelle</span>, <span class="hlFld-ContribAuthor ">C. Perpiñá  Viciano</span>, <span class="hlFld-ContribAuthor ">B.  Caspar</span>, <span class="hlFld-ContribAuthor ">M.  Arimont</span>, <span class="hlFld-ContribAuthor ">J.P.  Bebelman</span>, <span class="hlFld-ContribAuthor ">S.J.  Briddon</span>, <span class="hlFld-ContribAuthor ">C.  Hoffmann</span>, <span class="hlFld-ContribAuthor ">S.J.  Hill</span>, <span class="hlFld-ContribAuthor ">M.J.  Smit</span>, <span class="hlFld-ContribAuthor ">H.F.  Vischer</span>, <span class="hlFld-ContribAuthor ">M.  Wijtmans</span>, <span class="hlFld-ContribAuthor ">C.  de Graaf</span>, <span class="hlFld-ContribAuthor ">I.J.P.  de Esch</span>, <span class="hlFld-ContribAuthor ">R.  Leurs</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 631-649. <a href="https://doi.org/10.1016/j.ejmech.2018.10.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bexploration%252Band%252Bpharmacological%252Bevaluation%252Bof%252BN-substituted%252Bpiperidin-4-yl-methanamine%252BCXCR4%252Bchemokine%252Breceptor%252Bantagonists%26aulast%3DAdlere%26aufirst%3DI.%26date%3D2019%26volume%3D162%26spage%3D631%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dian  Peng</span>, <span class="hlFld-ContribAuthor ">Bin  Cao</span>, <span class="hlFld-ContribAuthor ">Ying-Jun  Zhou</span>, <span class="hlFld-ContribAuthor ">Ya-Qiu  Long</span>. </span><span class="cited-content_cbyCitation_article-title">The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>149 </em>, 148-169. <a href="https://doi.org/10.1016/j.ejmech.2018.02.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bchemical%252Bdiversity%252Band%252Bstructure-based%252Bevolution%252Bof%252Bnon-peptide%252BCXCR4%252Bantagonists%252Bwith%252Bdiverse%252Btherapeutic%252Bpotential%26aulast%3DPeng%26aufirst%3DDian%26date%3D2018%26volume%3D149%26spage%3D148%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raimon  Puig de la Bellacasa</span>, <span class="hlFld-ContribAuthor ">Albert  Gibert</span>, <span class="hlFld-ContribAuthor ">Jesús M.  Planesas</span>, <span class="hlFld-ContribAuthor ">Laia  Ros-Blanco</span>, <span class="hlFld-ContribAuthor ">Xavier  Batllori</span>, <span class="hlFld-ContribAuthor ">Roger  Badía</span>, <span class="hlFld-ContribAuthor ">Bonaventura  Clotet</span>, <span class="hlFld-ContribAuthor ">José  Esté</span>, <span class="hlFld-ContribAuthor ">Jordi  Teixidó</span>, <span class="hlFld-ContribAuthor ">José I.  Borrell</span>. </span><span class="cited-content_cbyCitation_article-title">Nitrogen positional scanning in tetramines active against HIV-1 as potential CXCR4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (4)
                                     , 1455-1472. <a href="https://doi.org/10.1039/C5OB02419F" title="DOI URL">https://doi.org/10.1039/C5OB02419F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02419F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02419F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DNitrogen%252Bpositional%252Bscanning%252Bin%252Btetramines%252Bactive%252Bagainst%252BHIV-1%252Bas%252Bpotential%252BCXCR4%252Binhibitors%26aulast%3DPuig%2Bde%2Bla%2BBellacasa%26aufirst%3DRaimon%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D4%26spage%3D1455%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Reker</span>, <span class="hlFld-ContribAuthor ">P.  Schneider</span>, <span class="hlFld-ContribAuthor ">G.  Schneider</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-objective active machine learning rapidly improves structure–activity models and reveals new protein–protein interaction inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2016,</strong> <em>7 </em>
                                    (6)
                                     , 3919-3927. <a href="https://doi.org/10.1039/C5SC04272K" title="DOI URL">https://doi.org/10.1039/C5SC04272K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5SC04272K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5SC04272K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DMulti-objective%252Bactive%252Bmachine%252Blearning%252Brapidly%252Bimproves%252Bstructure%2525E2%252580%252593activity%252Bmodels%252Band%252Breveals%252Bnew%252Bprotein%2525E2%252580%252593protein%252Binteraction%252Binhibitors%26aulast%3DReker%26aufirst%3DD.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D6%26spage%3D3919%26epage%3D3927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria  Vinader</span>, <span class="hlFld-ContribAuthor ">Djevdet S.  Ahmet</span>, <span class="hlFld-ContribAuthor ">Mohaned S.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Laurence H.  Patterson</span>, <span class="hlFld-ContribAuthor ">Kamyar  Afarinkia</span>, . </span><span class="cited-content_cbyCitation_article-title">Discovery and Computer Aided Potency Optimization of a Novel Class of Small Molecule CXCR4 Antagonists. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (10)
                                     , e78744. <a href="https://doi.org/10.1371/journal.pone.0078744" title="DOI URL">https://doi.org/10.1371/journal.pone.0078744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0078744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0078744%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DDiscovery%252Band%252BComputer%252BAided%252BPotency%252BOptimization%252Bof%252Ba%252BNovel%252BClass%252Bof%252BSmall%252BMolecule%252BCXCR4%252BAntagonists%26aulast%3DVinader%26aufirst%3DVictoria%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D10%26spage%3De78744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Noncyclam CXCR4 Inhibitor <b>1</b>, AMD3100 (<b>2</b>), and Stereoisomers of Compound <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Three Stereoisomers of Compound <b>1</b> (<b>1</b>(<i>R,R</i>), <b>1</b>(<i>S,S</i>), and the <i>meso</i> Form <b>1</b>(<i>S,R</i>)) and the Corresponding Tetrahydrochlorides <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antagonist effect and its related inhibition determination curves for <b>11</b>(<i>R,R</i>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MAPK and Akt pathway activation by CXCL12. Neurospheres were dissociated and counted, and an equal number of cells were seeded. After 24 h of EGF, FGF, and B27 starvation, cells were treated with 100 mg/mL of CXCL12 during 1 or 2 h. Levels of p-MAPK, p-Akt, and Tubulin were determined by immunoblotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. MAPK and Akt pathway inhibition by CXCR4 inhibitors AMD3100, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>). GBM2 neurospheres were dissociated, counted and an equal number of cells were seeded. Cells were treated or left untreated with CXCR4 inhibitors (1 μM) during 8 h. Levels of MAPK, p-Akt, Akt and Tubulin were determined by immunoblotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. MAPK and Akt pathway inhibition by CXCR4 inhibitors in the presence of CXCL12. GBM2 neurospheres were dissociated and counted. After 24 h of EGF, FGF and B27 starvation cells were treated or left untreated with 1 μM CXCR4 inhibitors AMD3100, <b>11</b>, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>) during 8 h and/or CXCL12 (100 ng/mL) during 1 h. Levels of p-MAPK, MAPK, p-Akt, Akt, and Tubulin were determined by immunoblotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of CXCR4 inhibitors on the CD44+ cell population in patient-derived GBM neurospheres. GBM neurosphere cultures were dissociated and counted, and an equal number of cells were seeded. Cells were treated with 1 μM of the indicated inhibitors (AMD3100, <b>11</b>, <b>11</b>(<i>R,R</i>), <b>11</b>(<i>S,S</i>), and <b>11</b>(<i>S,R</i>)) for 7 days. The percentage of cells expressing CD44 was determined by flow cytometry. Bar graphs show the ratio of CD44 low/CD44 null cells quantified by flow cytometry in the different conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Scheme of mouse model for human glioblastoma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/medium/jm-2012-00862u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of CXCR4 inhibitors AMD3100 and <b>11</b> on tumor growth. GBM1 neurospheres were dissociated and counted, and the same number of living cells was inoculated in the brain of NOD-SCID. Forty days after inoculation, the tumor size was determined through MRI and the tumor volume was quantified. The white box indicates an example of tumor detected by MRI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm300862u/production/images/large/jm-2012-00862u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300862u&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Brat, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellano-Sanchez, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devi, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Meir, E. G.</span><span> </span><span class="NLM_article-title">Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">920</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=920-927&author=D.+J.+Bratauthor=A.+A.+Castellano-Sanchezauthor=S.+B.+Hunterauthor=M.+Pecotauthor=C.+Cohenauthor=E.+H.+Hammondauthor=S.+N.+Deviauthor=B.+Kaurauthor=E.+G.+Van+Meir&title=Pseudopalisades+in+Glioblastoma+Are+Hypoxic%2C+Express+Extracellular+Matrix+Proteases%2C+and+Are+Formed+by+an+Actively+Migrating+Cell+Population"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrat%26aufirst%3DD.%2BJ.%26aulast%3DCastellano-Sanchez%26aufirst%3DA.%2BA.%26aulast%3DHunter%26aufirst%3DS.%2BB.%26aulast%3DPecot%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DC.%26aulast%3DHammond%26aufirst%3DE.%2BH.%26aulast%3DDevi%26aufirst%3DS.%2BN.%26aulast%3DKaur%26aufirst%3DB.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26atitle%3DPseudopalisades%2520in%2520Glioblastoma%2520Are%2520Hypoxic%252C%2520Express%2520Extracellular%2520Matrix%2520Proteases%252C%2520and%2520Are%2520Formed%2520by%2520an%2520Actively%2520Migrating%2520Cell%2520Population%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D920%26epage%3D927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Furnari, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachoo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukasa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stommel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinho, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavenee, W. K.</span><span> </span><span class="NLM_article-title">Malignant astrocytic glioma: Genetics, biology, and paths to treatment</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2683</span><span class="NLM_x">–</span> <span class="NLM_lpage">2710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1101%2Fgad.1596707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=17974913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2683-2710&author=F.+B.+Furnariauthor=T.+Fentonauthor=R.+M.+Bachooauthor=A.+Mukasaauthor=J.+M.+Stommelauthor=A.+Steghauthor=W.+C.+Hahnauthor=K.+L.+Ligonauthor=D.+N.+Louisauthor=C.+Brennanauthor=L.+Chinauthor=R.+A.+DePinhoauthor=W.+K.+Cavenee&title=Malignant+astrocytic+glioma%3A+Genetics%2C+biology%2C+and+paths+to+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Malignant astrocytic glioma: genetics, biology, and paths to treatment</span></div><div class="casAuthors">Furnari, Frank B.; Fenton, Tim; Bachoo, Robert M.; Mukasa, Akitake; Stommel, Jayne M.; Stegh, Alexander; Hahn, William C.; Ligon, Keith L.; Louis, David N.; Brennan, Cameron; Chin, Lynda; DePinho, Ronald A.; Cavenee, Webster K.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2683-2710</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Malignant astrocytic gliomas such as glioblastoma are the most common and lethal intracranial tumors.  These cancers exhibit a relentless malignant progression characterized by widespread invasion throughout the brain, resistance to traditional and newer targeted therapeutic approaches, destruction of normal brain tissue, and certain death.  The recent confluence of advances in stem cell biol., cell signaling, genome and computational science and genetic model systems have revolutionized our understanding of the mechanisms underlying the genetics, biol. and clin. behavior of glioblastoma.  This progress is fueling new opportunities for understanding the fundamental basis for development of this devastating disease and also novel therapies that, for the first time, portend meaningful clin. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDlfTN9OqeLLVg90H21EOLACvtfcHk0lg1kN6aPQlUzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitLrO&md5=5b89b311117f70e3708194afa9165414</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fgad.1596707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1596707%26sid%3Dliteratum%253Aachs%26aulast%3DFurnari%26aufirst%3DF.%2BB.%26aulast%3DFenton%26aufirst%3DT.%26aulast%3DBachoo%26aufirst%3DR.%2BM.%26aulast%3DMukasa%26aufirst%3DA.%26aulast%3DStommel%26aufirst%3DJ.%2BM.%26aulast%3DStegh%26aufirst%3DA.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DLigon%26aufirst%3DK.%2BL.%26aulast%3DLouis%26aufirst%3DD.%2BN.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26atitle%3DMalignant%2520astrocytic%2520glioma%253A%2520Genetics%252C%2520biology%252C%2520and%2520paths%2520to%2520treatment%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26spage%3D2683%26epage%3D2710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parada, L. F.</span><span> </span><span class="NLM_article-title">The molecular and genetic basis of neurological tumours</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1038%2Fnrc866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=12154354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslGqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=616-626&author=Y.+Zhuauthor=L.+F.+Parada&title=The+molecular+and+genetic+basis+of+neurological+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular and Genetic Basis of Neurological Tumours</span></div><div class="casAuthors">Zhu, Yuan; Parada, Luis F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">616-626</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There are no effective therapies for many tumors of the nervous system.  This is, in part, a consequence of their location within relatively inaccessible tissues.  It is also likely, however, that the unique characteristics of the cells that give rise to these tumors create a set of conditions that facilitate tumor development.  Here, the authors consider recent advances in mol. genetics, the development of mouse models and developmental neurobiol. as they relate to tumors of neuroectodermal origin.  It is likely that these advances will provide insight into underlying mechanisms and provide a rational framework for the development of effective interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpW4IsUYen4rVg90H21EOLACvtfcHk0ljcnFSeZsl5qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslGqsL0%253D&md5=53ac48227dbcaf7421994089dcdb6664</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc866%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DParada%26aufirst%3DL.%2BF.%26atitle%3DThe%2520molecular%2520and%2520genetic%2520basis%2520of%2520neurological%2520tumours%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D616%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Anido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sáez-Borderías, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzàlez-Juncà, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodón, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmona, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto-Sánchez, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barba, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Sáez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudkin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuartas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raventós, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Ricarte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poca, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Dorado, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahn, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yingling, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodón, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahuquillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seoane, J.</span><span> </span><span class="NLM_article-title">TGF-beta Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=655-668&author=J.+Anidoauthor=A.+S%C3%A1ez-Border%C3%ADasauthor=A.+Gonz%C3%A0lez-Junc%C3%A0author=L.+Rod%C3%B3nauthor=G.+Folchauthor=M.+A.+Carmonaauthor=R.+M.+Prieto-S%C3%A1nchezauthor=I.+Barbaauthor=E.+Mart%C3%ADnez-S%C3%A1ezauthor=L.+Prudkinauthor=I.+Cuartasauthor=C.+Ravent%C3%B3sauthor=F.+Mart%C3%ADnez-Ricarteauthor=M.+A.+Pocaauthor=D.+Garc%C3%ADa-Doradoauthor=M.+M.+Lahnauthor=J.+M.+Yinglingauthor=J.+Rod%C3%B3nauthor=J.+Sahuquilloauthor=J.+Baselgaauthor=J.+Seoane&title=TGF-beta+Receptor+Inhibitors+Target+the+CD44%28high%29%2FId1%28high%29+Glioma-Initiating+Cell+Population+in+Human+Glioblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnido%26aufirst%3DJ.%26aulast%3DS%25C3%25A1ez-Border%25C3%25ADas%26aufirst%3DA.%26aulast%3DGonz%25C3%25A0lez-Junc%25C3%25A0%26aufirst%3DA.%26aulast%3DRod%25C3%25B3n%26aufirst%3DL.%26aulast%3DFolch%26aufirst%3DG.%26aulast%3DCarmona%26aufirst%3DM.%2BA.%26aulast%3DPrieto-S%25C3%25A1nchez%26aufirst%3DR.%2BM.%26aulast%3DBarba%26aufirst%3DI.%26aulast%3DMart%25C3%25ADnez-S%25C3%25A1ez%26aufirst%3DE.%26aulast%3DPrudkin%26aufirst%3DL.%26aulast%3DCuartas%26aufirst%3DI.%26aulast%3DRavent%25C3%25B3s%26aufirst%3DC.%26aulast%3DMart%25C3%25ADnez-Ricarte%26aufirst%3DF.%26aulast%3DPoca%26aufirst%3DM.%2BA.%26aulast%3DGarc%25C3%25ADa-Dorado%26aufirst%3DD.%26aulast%3DLahn%26aufirst%3DM.%2BM.%26aulast%3DYingling%26aufirst%3DJ.%2BM.%26aulast%3DRod%25C3%25B3n%26aufirst%3DJ.%26aulast%3DSahuquillo%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DSeoane%26aufirst%3DJ.%26atitle%3DTGF-beta%2520Receptor%2520Inhibitors%2520Target%2520the%2520CD44%2528high%2529%252FId1%2528high%2529%2520Glioma-Initiating%2520Cell%2520Population%2520in%2520Human%2520Glioblastoma%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D655%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Visvader, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, G. J.</span><span> </span><span class="NLM_article-title">Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1038%2Fnrc2499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=18784658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=755-768&author=J.+E.+Visvaderauthor=G.+J.+Lindeman&title=Cancer+stem+cells+in+solid+tumours%3A+Accumulating+evidence+and+unresolved+questions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer stem cells in solid tumors: accumulating evidence and unresolved questions</span></div><div class="casAuthors">Visvader, Jane E.; Lindeman, Geoffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">755-768</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review article, the authors discuss the evidence supporting the existence of CSCs in solid tumors.  Solid tumors are an enormous cancer burden and a major therapeutic challenge.  The cancer stem cell (CSC) hypothesis provides an attractive cellular mechanism to account for the therapeutic refractoriness and dormant behavior exhibited by many of these tumors.  There is increasing evidence that diverse solid tumors are hierarchically organized and sustained by a distinct subpopulation of CSCs.  Direct evidence for the CSC hypothesis has recently emerged from mouse models of epithelial tumorigenesis, although alternative models of heterogeneity also seem to apply.  The clin. relevance of CSCs remains a fundamental issue but preliminary findings indicate that specific targeting may be possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBOh-v2SBeBbVg90H21EOLACvtfcHk0ljcnFSeZsl5qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtb3K&md5=7374ce009670073b88ad284dfeacbec3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc2499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2499%26sid%3Dliteratum%253Aachs%26aulast%3DVisvader%26aufirst%3DJ.%2BE.%26aulast%3DLindeman%26aufirst%3DG.%2BJ.%26atitle%3DCancer%2520stem%2520cells%2520in%2520solid%2520tumours%253A%2520Accumulating%2520evidence%2520and%2520unresolved%2520questions%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D755%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Este, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telenti, A.</span><span> </span><span class="NLM_article-title">HIV entry inhibitors</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=81-88&author=J.+A.+Esteauthor=A.+Telenti&title=HIV+entry+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEste%26aufirst%3DJ.%2BA.%26aulast%3DTelenti%26aufirst%3DA.%26atitle%3DHIV%2520entry%2520inhibitors%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26spage%3D81%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Tilton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doms, R. W.</span><span> </span><span class="NLM_article-title">Entry inhibitors in the treatment of HIV-1 infection</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2010&pages=91-100&author=J.+C.+Tiltonauthor=R.+W.+Doms&title=Entry+inhibitors+in+the+treatment+of+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTilton%26aufirst%3DJ.%2BC.%26aulast%3DDoms%26aufirst%3DR.%2BW.%26atitle%3DEntry%2520inhibitors%2520in%2520the%2520treatment%2520of%2520HIV-1%2520infection%26jtitle%3DAntiviral%2520Res.%26date%3D2010%26volume%3D85%26spage%3D91%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Pettersson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Nueno, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ros-Blanco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puig de La Bellacasa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabal, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batllori, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet-Codina, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armand-Ugón, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esté, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixidó, J.</span><span> </span><span class="NLM_article-title">Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1549-1557&author=S.+Petterssonauthor=V.+I.+P%C3%A9rez-Nuenoauthor=L.+Ros-Blancoauthor=R.+Puig+de+La+Bellacasaauthor=M.+O.+Rabalauthor=X.+Batlloriauthor=B.+Clotetauthor=I.+Clotet-Codinaauthor=M.+Armand-Ug%C3%B3nauthor=J.+A.+Est%C3%A9author=J.+I.+Borrellauthor=J.+Teixid%C3%B3&title=Discovery+of+novel+non-cyclam+polynitrogenated+CXCR4+coreceptor+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DS.%26aulast%3DP%25C3%25A9rez-Nueno%26aufirst%3DV.%2BI.%26aulast%3DRos-Blanco%26aufirst%3DL.%26aulast%3DPuig%2Bde%2BLa%2BBellacasa%26aufirst%3DR.%26aulast%3DRabal%26aufirst%3DM.%2BO.%26aulast%3DBatllori%26aufirst%3DX.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DClotet-Codina%26aufirst%3DI.%26aulast%3DArmand-Ug%25C3%25B3n%26aufirst%3DM.%26aulast%3DEst%25C3%25A9%26aufirst%3DJ.%2BA.%26aulast%3DBorrell%26aufirst%3DJ.%2BI.%26aulast%3DTeixid%25C3%25B3%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520novel%2520non-cyclam%2520polynitrogenated%2520CXCR4%2520coreceptor%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1549%26epage%3D1557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bian, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ping, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. M.</span><span> </span><span class="NLM_article-title">Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival</span> <span class="citation_source-journal">Neurosurgery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">570</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=570-578&author=X.+W.+Bianauthor=S.+X.+Yangauthor=J.+H.+Chenauthor=Y.+F.+Pingauthor=X.+D.+Zhouauthor=Q.+L.+Wangauthor=X.+F.+Jiangauthor=W.+Gongauthor=H.+L.+Xiaoauthor=L.+L.+Duauthor=Z.+Q.+Chenauthor=W.+Zhaoauthor=J.+Q.+Shiauthor=J.+M.+Wang&title=Preferential+expression+of+chemokine+receptor+CXCR4+by+highly+malignant+human+gliomas+and+its+association+with+poor+patient+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DX.%2BW.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DPing%26aufirst%3DY.%2BF.%26aulast%3DZhou%26aufirst%3DX.%2BD.%26aulast%3DWang%26aufirst%3DQ.%2BL.%26aulast%3DJiang%26aufirst%3DX.%2BF.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DH.%2BL.%26aulast%3DDu%26aufirst%3DL.%2BL.%26aulast%3DChen%26aufirst%3DZ.%2BQ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DJ.%2BQ.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26atitle%3DPreferential%2520expression%2520of%2520chemokine%2520receptor%2520CXCR4%2520by%2520highly%2520malignant%2520human%2520gliomas%2520and%2520its%2520association%2520with%2520poor%2520patient%2520survival%26jtitle%3DNeurosurgery%26date%3D2007%26volume%3D61%26spage%3D570%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Tseng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasquez-Medrano, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. M.</span><span> </span><span class="NLM_article-title">Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1805</span><span class="NLM_x">–</span> <span class="NLM_lpage">1809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1038%2Fbjc.2011.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=21587260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntV2hsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2011&pages=1805-1809&author=D.+Tsengauthor=D.+A.+Vasquez-Medranoauthor=J.+M.+Brown&title=Targeting+SDF-1%2FCXCR4+to+inhibit+tumour+vasculature+for+treatment+of+glioblastomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting SDF-1/CXCR4 to inhibit tumor vasculature for treatment of glioblastomas</span></div><div class="casAuthors">Tseng, D.; Vasquez-Medrano, D. A.; Brown, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1805-1809</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Local recurrence of glioblastomas is a major cause of patient mortality after definitive treatment.  This review discusses the roles of the chemokine stromal cell-derived factor-1 and its receptor CXC chemokine receptor 4 (CXCR4) in affecting the sensitivity of glioblastomas to irradn.  Blocking these mols. prevents or delays tumor recurrence after irradn. by inhibiting the recruitment of CD11b+ monocytes/macrophages that participate in revascularising the tumor.  We review the literature pertaining to the mechanism by which revascularisation occurs following tumor irradn. using exptl. models.  Areas of interest and debate in the literature include the process by which endothelial cells die after irradn. and the identity/origin of the cells that reconstitute the tumor blood vessels after injury.  Understanding the processes that mediate tumor revascularisation will guide the improvement of clin. strategies for preventing recurrence of glioblastoma after irradn.  British Journal of Cancer (2011) 104, 1805-1809; doi:10.1038/bjc.2011.169 www.bjcancer.com Published online 17 May 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ey-Qxw4cYLVg90H21EOLACvtfcHk0liCPi92u8F6hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntV2hsb8%253D&md5=7f65a9048f936b80a79b39686dc0c54f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2011.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2011.169%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DD.%26aulast%3DVasquez-Medrano%26aufirst%3DD.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26atitle%3DTargeting%2520SDF-1%252FCXCR4%2520to%2520inhibit%2520tumour%2520vasculature%2520for%2520treatment%2520of%2520glioblastomas%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2011%26volume%3D104%26spage%3D1805%26epage%3D1809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Teicher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S. P.</span><span> </span><span class="NLM_article-title">CXCL12 (SDF-1)/CXCR4 pathway in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2931</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1158%2F1078-0432.CCR-09-2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=20484021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXms1Ojs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2927-2931&author=B.+A.+Teicherauthor=S.+P.+Fricker&title=CXCL12+%28SDF-1%29%2FCXCR4+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12 (SDF-1)/CXCR4 Pathway in Cancer</span></div><div class="casAuthors">Teicher, Beverly A.; Fricker, Simon P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2927-2931</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Chemokines, small proinflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion.  The chemokine CXCL12 [stromal cell-derived factor-1 (SDF-1)] binds primarily to CXC receptor 4 (CXCR4; CD184).  The binding of CXCL12 to CXCR4 induces intracellular signaling through several divergent pathways initiating signals related to chemotaxis, cell survival and/or proliferation, increase in intracellular calcium, and gene transcription.  CXCR4 is expressed on multiple cell types including lymphocytes, hematopoietic stem cells, endothelial and epithelial cells, and cancer cells.  The CXCL12/CXCR4 axis is involved in tumor progression, angiogenesis, metastasis, and survival.  This pathway is a target for therapeutics that can block the CXCL12/CXCR4 interaction or inhibit downstream intracellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosuc1QGMW7LbVg90H21EOLACvtfcHk0liCPi92u8F6hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXms1Ojs7o%253D&md5=ac1e120fac46488d6f8bb1fc7c6741c2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-2329%26sid%3Dliteratum%253Aachs%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DCXCL12%2520%2528SDF-1%2529%252FCXCR4%2520pathway%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D2927%26epage%3D2931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Terasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemori, M.</span><span> </span><span class="NLM_article-title">CXCL12/CXCR4 signaling in malignant brain tumors: A potential pharmacological therapeutic target</span> <span class="citation_source-journal">Brain Tumor Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1007%2Fs10014-010-0013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=21210239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGjs73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=89-97&author=M.+Terasakiauthor=Y.+Sugitaauthor=F.+Arakawaauthor=Y.+Okadaauthor=K.+Ohshimaauthor=M.+Shigemori&title=CXCL12%2FCXCR4+signaling+in+malignant+brain+tumors%3A+A+potential+pharmacological+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target</span></div><div class="casAuthors">Terasaki, Mizuhiko; Sugita, Yasuo; Arakawa, Fumiko; Okada, Yosuke; Ohshima, Koichi; Shigemori, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Brain Tumor Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">BTPAFM</span>;
        ISSN:<span class="NLM_cas:issn">1433-7398</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">A review.  Chemokines are 8- to 12-kDa peptides that function as chemoattractant cytokines involved in cell activation, differentiation, and trafficking.  Chemokines bind to specific G-protein-coupled, seven-span transmembrane receptors on the plasma membrane of target cells.  Chemokine (C-X-C motif) ligand 12 (CXCL12), an alpha-chemokine that binds to G-protein-coupled chemokine (C-X-C motif) receptor 4 (CXCR4), plays an important and unique role in the regulation of stem/progenitor-cell trafficking.  As CXCR4 is expressed on several cancer cells, these CXCR4-pos. cancer cells may metastasize to organs that secrete/express CXCL12.  Regarding brain tumors, recent data demonstrate that glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via the CXCL12/CXCR4 pathway.  In addn., CXCL12/CXCR4 have recently been shown to be expressed in primary central nervous system (PCNS) lymphomas, and a role for chemokines in the pathogenesis of PCNS lymphomas was suggested.  This review focuses on current knowledge regarding the biol. of the CXCL12/CXCR4 pathway in the context of understanding their potential role in malignant gliomas and PCNS lymphoma development.  The CXCL12/CXCR4 interaction as a therapeutic target for malignant brain tumors is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvY1lkFur35rVg90H21EOLACvtfcHk0lhwtYlqQX3Ucg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGjs73F&md5=c5bc15e1589f607e7480f0e769fda7a0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs10014-010-0013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10014-010-0013-1%26sid%3Dliteratum%253Aachs%26aulast%3DTerasaki%26aufirst%3DM.%26aulast%3DSugita%26aufirst%3DY.%26aulast%3DArakawa%26aufirst%3DF.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DOhshima%26aufirst%3DK.%26aulast%3DShigemori%26aufirst%3DM.%26atitle%3DCXCL12%252FCXCR4%2520signaling%2520in%2520malignant%2520brain%2520tumors%253A%2520A%2520potential%2520pharmacological%2520therapeutic%2520target%26jtitle%3DBrain%2520Tumor%2520Pathol.%26date%3D2011%26volume%3D28%26spage%3D89%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">do Carmo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalheiro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, M. C.</span><span> </span><span class="NLM_article-title">CXCL12/CXCR4 promotes motility and proliferation of glioma cells</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.4161%2Fcbt.9.1.10342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=19923906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Wjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=56-65&author=A.+do+Carmoauthor=I.+Patricioauthor=M.+T.+Cruzauthor=H.+Carvalheiroauthor=C.+R.+Oliveiraauthor=M.+C.+Lopes&title=CXCL12%2FCXCR4+promotes+motility+and+proliferation+of+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12/CXCR4 promotes motility and proliferation of glioma cells</span></div><div class="casAuthors">do Carmo, Analia; Patricio, Ines; Cruz, Maria T.; Carvalheiro, Helena; Oliveira, Catarina R.; Lopes, Maria C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-65</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is the most aggressive and malignant brain tumor.  Recent studies indicated that glioma samples are characterized by increased expression of CXCR4, the CXCL12/SDF-1 chemokine receptor.  To better understand the role of CXCR4 in GBM biol. we performed an integrated study where we simultaneously evaluate the contribution of the CXCR4/CXCL12 signaling pathway to the proliferation, survival and motility of a human GBM cell line.  Our results indicated that CXCR4/CXCL12 axis induced an increase in cell proliferation and in cell motility.  The blockage of CXCR4 induced a significant increase of apoptosis.  Together, our results indicated that CXCR4/CXCL12 signalling pathway may contribute to GBM development and emphasize the therapeutic potential of this pathway in patients with GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkyHcwVCIEWbVg90H21EOLACvtfcHk0lhwtYlqQX3Ucg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Wjt7Y%253D&md5=0c78d3de5d3e72ccae5f42cb064bf27f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4161%2Fcbt.9.1.10342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.9.1.10342%26sid%3Dliteratum%253Aachs%26aulast%3Ddo%2BCarmo%26aufirst%3DA.%26aulast%3DPatricio%26aufirst%3DI.%26aulast%3DCruz%26aufirst%3DM.%2BT.%26aulast%3DCarvalheiro%26aufirst%3DH.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26aulast%3DLopes%26aufirst%3DM.%2BC.%26atitle%3DCXCL12%252FCXCR4%2520promotes%2520motility%2520and%2520proliferation%2520of%2520glioma%2520cells%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D56%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Peñuelas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto-Sánchez, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barba, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuartas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Dorado, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poca, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahuquillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seoane, J.</span><span> </span><span class="NLM_article-title">TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma</span> <span class="citation_source-journal">Cancer Cell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=315-327&issue=4&author=S.+Pe%C3%B1uelasauthor=J.+Anidoauthor=R.+M.+Prieto-S%C3%A1nchezauthor=G.+Folchauthor=I.+Barbaauthor=I.+Cuartasauthor=D.+Garc%C3%ADa-Doradoauthor=M.+A.+Pocaauthor=J.+Sahuquilloauthor=J.+Baselgaauthor=J.+Seoane&title=TGF-beta+increases+glioma-initiating+cell+self-renewal+through+the+induction+of+LIF+in+human+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25C3%25B1uelas%26aufirst%3DS.%26aulast%3DAnido%26aufirst%3DJ.%26aulast%3DPrieto-S%25C3%25A1nchez%26aufirst%3DR.%2BM.%26aulast%3DFolch%26aufirst%3DG.%26aulast%3DBarba%26aufirst%3DI.%26aulast%3DCuartas%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Dorado%26aufirst%3DD.%26aulast%3DPoca%26aufirst%3DM.%2BA.%26aulast%3DSahuquillo%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DSeoane%26aufirst%3DJ.%26atitle%3DTGF-beta%2520increases%2520glioma-initiating%2520cell%2520self-renewal%2520through%2520the%2520induction%2520of%2520LIF%2520in%2520human%2520glioblastoma%26jtitle%3DCancer%2520Cell.%26date%3D2009%26volume%3D15%26issue%3D4%26spage%3D315%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span> </span><span class="NLM_article-title">A practical preparation of (<i>R</i>)- and (<i>S</i>)-<i>N</i>-Boc-2-methylpiperidines</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=1275-1278&author=D.+Dollerauthor=R.+Daviesauthor=S.+Chackalamannil&title=A+practical+preparation+of+%28R%29-+and+%28S%29-N-Boc-2-methylpiperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DChackalamannil%26aufirst%3DS.%26atitle%3DA%2520practical%2520preparation%2520of%2520%2528R%2529-%2520and%2520%2528S%2529-N-Boc-2-methylpiperidines%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1997%26volume%3D8%26spage%3D1275%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Apelt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertz, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Development of a new class of nonimidazole histamine H<sub>3</sub> receptor ligands with combined inhibitory histamine <i>N</i>-methyltransferase activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0110845" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1128-1141&author=J.+Apeltauthor=X.+Ligneauauthor=H.+H.+Pertzauthor=J.+Arrangauthor=C.+R.+Ganellinauthor=J.+Schwartzauthor=W.+Schunackauthor=H.+Stark&title=Development+of+a+new+class+of+nonimidazole+histamine+H3+receptor+ligands+with+combined+inhibitory+histamine+N-methyltransferase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm0110845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0110845%26sid%3Dliteratum%253Aachs%26aulast%3DApelt%26aufirst%3DJ.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DPertz%26aufirst%3DH.%2BH.%26aulast%3DArrang%26aufirst%3DJ.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DJ.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520a%2520new%2520class%2520of%2520nonimidazole%2520histamine%2520H3%2520receptor%2520ligands%2520with%2520combined%2520inhibitory%2520histamine%2520N-methyltransferase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1128%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jo, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pae, A. N.</span><span> </span><span class="NLM_article-title">Novel T-type calcium channel blockers: Dioxoquinazoline carboxamide derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=365-373&author=M.+N.+Joauthor=H.+J.+Seoauthor=Y.+Kimauthor=S.+H.+Seoauthor=H.+Rhimauthor=Y.+S.+Choauthor=J.+H.+Chaauthor=H.+Y.+Kohauthor=H.+Chooauthor=A.+N.+Pae&title=Novel+T-type+calcium+channel+blockers%3A+Dioxoquinazoline+carboxamide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DM.%2BN.%26aulast%3DSeo%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DSeo%26aufirst%3DS.%2BH.%26aulast%3DRhim%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DCha%26aufirst%3DJ.%2BH.%26aulast%3DKoh%26aufirst%3DH.%2BY.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DPae%26aufirst%3DA.%2BN.%26atitle%3DNovel%2520T-type%2520calcium%2520channel%2520blockers%253A%2520Dioxoquinazoline%2520carboxamide%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D365%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, V. W.</span><span> </span><span class="NLM_article-title">CXCR4 is a major chemokine receptor on glioma cells and mediates their survival</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">49481</span><span class="NLM_x">–</span> <span class="NLM_lpage">49487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=49481-49487&author=Y.+Zhouauthor=P.+H.+Larsenauthor=Ch.+Haoauthor=V.+W.+Yong&title=CXCR4+is+a+major+chemokine+receptor+on+glioma+cells+and+mediates+their+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26aulast%3DHao%26aufirst%3DCh.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DCXCR4%2520is%2520a%2520major%2520chemokine%2520receptor%2520on%2520glioma%2520cells%2520and%2520mediates%2520their%2520survival%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D49481%26epage%3D49487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mathes, C.</span><span> </span><span class="NLM_article-title">QPatch: The past, present and future of automated patch clamp</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300862u&amp;key=10.1517%2F14728222.10.2.319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300862u&amp;key=16548779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300862u&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVOmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=319-327&author=C.+Mathes&title=QPatch%3A+The+past%2C+present+and+future+of+automated+patch+clamp"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">QPatch: the past, present and future of automated patch clamp</span></div><div class="casAuthors">Mathes, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-327</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The QPatch 16 significantly increases throughput for gigaseal patch clamp expts., making direct measurements in ion channel drug discovery and safety testing feasible.  Released to the market in the Autumn of 2004 by Sophion Bioscience, the QPatch originated from work done at NeuroSearch (Denmark) in the early days of automated patch clamp.  Today, the QPatch provides many unique features.  For example, only the QPatch includes an automated cell prepn. station making several hours of unattended operation possible.  The 16-channel electrode array, called the QPlate, includes glass-coated microfluidic channels for less compd. absorption and, hence, more accurate IC50 values.  The microfluidic pathways also allow for very small amts. of compd. used for each expt. (∼ 5 μl per addn.).  Only the QPatch has four independent pipetting heads for more efficient liq. handling (esp. for ligand-gated ion channel expts.).  Patch clamp recordings with the QPatch match the high quality of conventional patch clamp and in some cases the results are even better.  For example, only the QPatch includes 100% series resistance compensation for the elimination of false positives due to voltage errors.  Finally, the modular QPatch 16 was designed with more channels in mind.  The upgrade pathway to 48-channels (the QPatch HT) will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqywPZMP8PNwrVg90H21EOLACvtfcHk0lhDz_s9tsjsPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVOmt7k%253D&md5=7dcd02a69652955e261f6928fbb76b81</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.2.319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.2.319%26sid%3Dliteratum%253Aachs%26aulast%3DMathes%26aufirst%3DC.%26atitle%3DQPatch%253A%2520The%2520past%252C%2520present%2520and%2520future%2520of%2520automated%2520patch%2520clamp%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D319%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sturgill, T. W.</span><span> </span><span class="NLM_article-title">MAP kinase: It’s been longer than fifteen minutes</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2008&pages=1-4&author=T.+W.+Sturgill&title=MAP+kinase%3A+It%E2%80%99s+been+longer+than+fifteen+minutes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSturgill%26aufirst%3DT.%2BW.%26atitle%3DMAP%2520kinase%253A%2520It%25E2%2580%2599s%2520been%2520longer%2520than%2520fifteen%2520minutes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D371%26spage%3D1%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Rubin, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieran, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, R. A.</span><span> </span><span class="NLM_article-title">A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">13513</span><span class="NLM_x">–</span> <span class="NLM_lpage">13518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13513-13518&issue=23&author=J.+B.+Rubinauthor=A.+L.+Kungauthor=R.+S.+Kleinauthor=J.+A.+Chanauthor=Y.+Sunauthor=K.+Schmidtauthor=M.+W.+Kieranauthor=A.+D.+Lusterauthor=R.+A.+Segal&title=A+small-molecule+antagonist+of+CXCR4+inhibits+intracranial+growth+of+primary+brain+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DJ.%2BB.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520CXCR4%2520inhibits%2520intracranial%2520growth%2520of%2520primary%2520brain%2520tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26issue%3D23%26spage%3D13513%26epage%3D13518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Gonzalez-Ortega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Este, J. A.</span><span> </span><span class="NLM_article-title">Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2011&pages=479-483&author=E.+Gonzalez-Ortegaauthor=E.+Ballanaauthor=R.+Badiaauthor=B.+Clotetauthor=J.+A.+Este&title=Compensatory+mutations+rescue+the+virus+replicative+capacity+of+VIRIP-resistant+HIV-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Ortega%26aufirst%3DE.%26aulast%3DBallana%26aufirst%3DE.%26aulast%3DBadia%26aufirst%3DR.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DEste%26aufirst%3DJ.%2BA.%26atitle%3DCompensatory%2520mutations%2520rescue%2520the%2520virus%2520replicative%2520capacity%2520of%2520VIRIP-resistant%2520HIV-1%26jtitle%3DAntiviral%2520Res.%26date%3D2011%26volume%3D92%26spage%3D479%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a href="/doi/suppl/10.1021/jm300862u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23301"></div></div></div></div></div><hr /></hr><p class="last">Spectral data for compounds <b>6</b>(<i>S</i>), <b>6</b>(<i>R</i>), <b>3</b>(<i>S</i>), <b>3</b>(<i>R</i>), <b>1</b>(<i>S,S</i>), <b>11</b>(<i>S,S</i>), <b>1</b>(<i>R,R</i>), <b>11</b>(<i>R,R</i>), <b>9</b>(<i>S</i>), <b>10</b>(<i>S</i>), and <b>11</b>(<i>S,R</i>). High-performance liquid chromatography (HPLC) analytical profile for <b>11</b>(<i>S,S</i>), <b>11</b>(<i>R,R</i>), and <b>11</b>(<i>S,R</i>). CD44 low/CD44 null analysis. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300862u/suppl_file/jm300862u_si_001.pdf">jm300862u_si_001.pdf (2.39 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300862u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-17%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm300862u" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300862u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667983638c82d1cf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
